| 2.3 |
7.0 |
GO:0046586 |
regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
| 1.8 |
10.8 |
GO:0002803 |
positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) positive regulation of antibacterial peptide production(GO:0002803) |
| 1.8 |
8.8 |
GO:0061143 |
alveolar primary septum development(GO:0061143) |
| 1.7 |
5.2 |
GO:2001037 |
tongue muscle cell differentiation(GO:0035981) positive regulation of skeletal muscle fiber differentiation(GO:1902811) regulation of tongue muscle cell differentiation(GO:2001035) positive regulation of tongue muscle cell differentiation(GO:2001037) |
| 1.6 |
6.5 |
GO:0046110 |
xanthine metabolic process(GO:0046110) |
| 1.6 |
1.6 |
GO:0036072 |
intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
| 1.5 |
4.6 |
GO:0042369 |
vitamin D catabolic process(GO:0042369) |
| 1.5 |
4.5 |
GO:0042938 |
dipeptide transport(GO:0042938) |
| 1.4 |
12.5 |
GO:0031444 |
slow-twitch skeletal muscle fiber contraction(GO:0031444) |
| 1.3 |
5.4 |
GO:0010900 |
negative regulation of phosphatidylcholine catabolic process(GO:0010900) |
| 1.2 |
3.6 |
GO:0051780 |
mevalonate transport(GO:0015728) behavioral response to nutrient(GO:0051780) |
| 1.2 |
3.6 |
GO:0006535 |
cysteine biosynthetic process from serine(GO:0006535) |
| 1.2 |
3.5 |
GO:0046521 |
sphingoid catabolic process(GO:0046521) |
| 1.2 |
3.5 |
GO:0009443 |
pyridoxal 5'-phosphate salvage(GO:0009443) |
| 1.1 |
5.6 |
GO:0018101 |
protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
| 1.1 |
2.2 |
GO:1905167 |
positive regulation of lysosomal protein catabolic process(GO:1905167) |
| 1.0 |
1.0 |
GO:0006668 |
sphinganine-1-phosphate metabolic process(GO:0006668) |
| 1.0 |
3.1 |
GO:1904298 |
positive regulation of neutrophil degranulation(GO:0043315) cellular response to gravity(GO:0071258) positive regulation of neutrophil activation(GO:1902565) regulation of transcytosis(GO:1904298) positive regulation of transcytosis(GO:1904300) regulation of maternal process involved in parturition(GO:1904301) positive regulation of maternal process involved in parturition(GO:1904303) response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904316) cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904317) |
| 1.0 |
3.1 |
GO:0098838 |
reduced folate transmembrane transport(GO:0098838) |
| 1.0 |
2.1 |
GO:2000309 |
positive regulation of tumor necrosis factor (ligand) superfamily member 11 production(GO:2000309) |
| 1.0 |
1.0 |
GO:1903923 |
protein processing in phagocytic vesicle(GO:1900756) regulation of protein processing in phagocytic vesicle(GO:1903921) positive regulation of protein processing in phagocytic vesicle(GO:1903923) |
| 1.0 |
5.1 |
GO:2000354 |
regulation of ovarian follicle development(GO:2000354) |
| 1.0 |
21.7 |
GO:0016540 |
protein autoprocessing(GO:0016540) |
| 1.0 |
6.9 |
GO:0007386 |
compartment pattern specification(GO:0007386) |
| 1.0 |
4.8 |
GO:0002317 |
plasma cell differentiation(GO:0002317) |
| 1.0 |
7.6 |
GO:0031642 |
negative regulation of myelination(GO:0031642) |
| 1.0 |
3.8 |
GO:0010899 |
regulation of phosphatidylcholine catabolic process(GO:0010899) |
| 0.9 |
10.4 |
GO:0060753 |
regulation of mast cell chemotaxis(GO:0060753) |
| 0.9 |
2.8 |
GO:0052047 |
interaction with other organism via secreted substance involved in symbiotic interaction(GO:0052047) |
| 0.9 |
2.8 |
GO:0097187 |
dentinogenesis(GO:0097187) |
| 0.9 |
7.4 |
GO:0035583 |
sequestering of TGFbeta in extracellular matrix(GO:0035583) |
| 0.9 |
2.7 |
GO:0043163 |
cell envelope organization(GO:0043163) external encapsulating structure organization(GO:0045229) |
| 0.9 |
2.6 |
GO:0006742 |
NADP catabolic process(GO:0006742) pyridine nucleotide catabolic process(GO:0019364) |
| 0.8 |
2.5 |
GO:0035623 |
regulation of pronephros size(GO:0035565) renal glucose absorption(GO:0035623) |
| 0.8 |
2.5 |
GO:0018153 |
isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine(GO:0018153) isopeptide cross-linking(GO:0018262) |
| 0.8 |
3.2 |
GO:1904448 |
negative regulation of gamma-aminobutyric acid secretion(GO:0014053) aspartate secretion(GO:0061528) regulation of aspartate secretion(GO:1904448) positive regulation of aspartate secretion(GO:1904450) |
| 0.8 |
2.4 |
GO:1902534 |
single-organism membrane invagination(GO:1902534) |
| 0.8 |
4.7 |
GO:0097070 |
ductus arteriosus closure(GO:0097070) |
| 0.8 |
6.9 |
GO:0038028 |
insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
| 0.8 |
3.8 |
GO:0031959 |
mineralocorticoid receptor signaling pathway(GO:0031959) |
| 0.8 |
3.8 |
GO:0032929 |
negative regulation of superoxide anion generation(GO:0032929) |
| 0.8 |
2.3 |
GO:1900126 |
negative regulation of hyaluronan biosynthetic process(GO:1900126) |
| 0.7 |
3.0 |
GO:1904565 |
response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
| 0.7 |
4.5 |
GO:0032252 |
secretory granule localization(GO:0032252) |
| 0.7 |
1.5 |
GO:1903519 |
apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
| 0.7 |
6.6 |
GO:0048050 |
post-embryonic eye morphogenesis(GO:0048050) |
| 0.7 |
0.7 |
GO:0061298 |
retina vasculature development in camera-type eye(GO:0061298) |
| 0.7 |
2.2 |
GO:2000777 |
positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia(GO:2000777) |
| 0.7 |
3.6 |
GO:0032487 |
regulation of Rap protein signal transduction(GO:0032487) |
| 0.7 |
2.1 |
GO:2000097 |
regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
| 0.7 |
7.6 |
GO:0070574 |
cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
| 0.7 |
0.7 |
GO:0021696 |
cerebellum morphogenesis(GO:0021587) cerebellar cortex development(GO:0021695) cerebellar cortex morphogenesis(GO:0021696) |
| 0.7 |
4.1 |
GO:0030421 |
defecation(GO:0030421) |
| 0.7 |
5.5 |
GO:0003065 |
positive regulation of heart rate by epinephrine(GO:0003065) |
| 0.7 |
1.3 |
GO:2000646 |
positive regulation of receptor catabolic process(GO:2000646) |
| 0.7 |
3.3 |
GO:0046340 |
diacylglycerol catabolic process(GO:0046340) |
| 0.7 |
5.9 |
GO:0086073 |
bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
| 0.7 |
0.7 |
GO:0048733 |
sebaceous gland development(GO:0048733) |
| 0.6 |
0.6 |
GO:0010757 |
negative regulation of plasminogen activation(GO:0010757) |
| 0.6 |
3.2 |
GO:0036324 |
vascular endothelial growth factor receptor-2 signaling pathway(GO:0036324) |
| 0.6 |
1.9 |
GO:0043449 |
cellular alkene metabolic process(GO:0043449) |
| 0.6 |
3.8 |
GO:0021834 |
chemorepulsion involved in embryonic olfactory bulb interneuron precursor migration(GO:0021834) |
| 0.6 |
5.6 |
GO:0015705 |
iodide transport(GO:0015705) |
| 0.6 |
10.0 |
GO:0050861 |
positive regulation of B cell receptor signaling pathway(GO:0050861) |
| 0.6 |
1.2 |
GO:0032196 |
transposition(GO:0032196) |
| 0.6 |
1.9 |
GO:0070634 |
transepithelial ammonium transport(GO:0070634) |
| 0.6 |
1.8 |
GO:0045658 |
regulation of neutrophil differentiation(GO:0045658) negative regulation of neutrophil differentiation(GO:0045659) |
| 0.6 |
1.8 |
GO:0034970 |
histone H3-R2 methylation(GO:0034970) |
| 0.6 |
1.7 |
GO:0010725 |
regulation of primitive erythrocyte differentiation(GO:0010725) eosinophil fate commitment(GO:0035854) |
| 0.6 |
3.4 |
GO:0045218 |
zonula adherens maintenance(GO:0045218) |
| 0.6 |
0.6 |
GO:2000196 |
positive regulation of female gonad development(GO:2000196) |
| 0.6 |
2.2 |
GO:0009257 |
10-formyltetrahydrofolate biosynthetic process(GO:0009257) |
| 0.6 |
2.8 |
GO:1901503 |
ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
| 0.6 |
6.7 |
GO:0098887 |
neurotransmitter receptor transport, endosome to postsynaptic membrane(GO:0098887) |
| 0.6 |
0.6 |
GO:0090345 |
cellular organohalogen metabolic process(GO:0090345) cellular organofluorine metabolic process(GO:0090346) |
| 0.5 |
3.3 |
GO:0071163 |
DNA replication preinitiation complex assembly(GO:0071163) |
| 0.5 |
1.1 |
GO:0043585 |
nose morphogenesis(GO:0043585) |
| 0.5 |
0.5 |
GO:1904933 |
regulation of cell proliferation in midbrain(GO:1904933) |
| 0.5 |
0.5 |
GO:2001056 |
positive regulation of cysteine-type endopeptidase activity(GO:2001056) |
| 0.5 |
1.1 |
GO:0071963 |
establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
| 0.5 |
6.4 |
GO:0061087 |
positive regulation of histone H3-K27 methylation(GO:0061087) |
| 0.5 |
1.6 |
GO:1904481 |
response to tetrahydrofolate(GO:1904481) cellular response to tetrahydrofolate(GO:1904482) |
| 0.5 |
0.5 |
GO:0048073 |
regulation of eye pigmentation(GO:0048073) |
| 0.5 |
3.2 |
GO:1900748 |
positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
| 0.5 |
1.6 |
GO:1902910 |
regulation of monophenol monooxygenase activity(GO:0032771) positive regulation of monophenol monooxygenase activity(GO:0032773) negative regulation of catagen(GO:0051796) regulation of hair cycle by canonical Wnt signaling pathway(GO:0060901) positive regulation of melanosome transport(GO:1902910) |
| 0.5 |
4.8 |
GO:0070236 |
negative regulation of activation-induced cell death of T cells(GO:0070236) |
| 0.5 |
2.1 |
GO:0033159 |
negative regulation of protein import into nucleus, translocation(GO:0033159) |
| 0.5 |
3.2 |
GO:0070458 |
cellular detoxification of nitrogen compound(GO:0070458) |
| 0.5 |
1.6 |
GO:0071790 |
spindle pole body duplication(GO:0030474) spindle pole body organization(GO:0051300) spindle pole body localization(GO:0070631) establishment of spindle pole body localization(GO:0070632) spindle pole body localization to nuclear envelope(GO:0071789) establishment of spindle pole body localization to nuclear envelope(GO:0071790) |
| 0.5 |
0.5 |
GO:0042159 |
lipoprotein catabolic process(GO:0042159) |
| 0.5 |
2.1 |
GO:1902499 |
positive regulation of protein autoubiquitination(GO:1902499) |
| 0.5 |
1.0 |
GO:1904684 |
negative regulation of metalloendopeptidase activity(GO:1904684) |
| 0.5 |
1.5 |
GO:0061073 |
ciliary body morphogenesis(GO:0061073) |
| 0.5 |
1.5 |
GO:0000294 |
nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay(GO:0000294) |
| 0.5 |
2.0 |
GO:0051562 |
negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
| 0.5 |
0.5 |
GO:0036466 |
synaptic vesicle recycling via endosome(GO:0036466) |
| 0.5 |
2.5 |
GO:2000969 |
positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
| 0.5 |
1.5 |
GO:0002384 |
hepatic immune response(GO:0002384) |
| 0.5 |
6.0 |
GO:0048711 |
positive regulation of astrocyte differentiation(GO:0048711) |
| 0.5 |
2.0 |
GO:0014846 |
esophagus smooth muscle contraction(GO:0014846) |
| 0.5 |
3.0 |
GO:0034436 |
glycoprotein transport(GO:0034436) |
| 0.5 |
2.0 |
GO:0007538 |
primary sex determination(GO:0007538) |
| 0.5 |
2.4 |
GO:0018125 |
peptidyl-cysteine methylation(GO:0018125) |
| 0.5 |
6.8 |
GO:0010739 |
positive regulation of protein kinase A signaling(GO:0010739) |
| 0.5 |
1.5 |
GO:0002276 |
basophil activation involved in immune response(GO:0002276) |
| 0.5 |
1.5 |
GO:1903926 |
signal transduction involved in intra-S DNA damage checkpoint(GO:0072428) response to bisphenol A(GO:1903925) cellular response to bisphenol A(GO:1903926) |
| 0.5 |
1.0 |
GO:0010165 |
response to X-ray(GO:0010165) |
| 0.5 |
3.9 |
GO:0038060 |
nitric oxide-cGMP-mediated signaling pathway(GO:0038060) |
| 0.5 |
1.9 |
GO:1901205 |
regulation of adrenergic receptor signaling pathway involved in heart process(GO:1901204) negative regulation of adrenergic receptor signaling pathway involved in heart process(GO:1901205) |
| 0.5 |
0.5 |
GO:2000177 |
regulation of neural precursor cell proliferation(GO:2000177) |
| 0.5 |
1.0 |
GO:0048843 |
negative regulation of axon extension involved in axon guidance(GO:0048843) |
| 0.5 |
2.4 |
GO:0090402 |
oncogene-induced cell senescence(GO:0090402) |
| 0.5 |
1.9 |
GO:0035625 |
epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) |
| 0.5 |
2.8 |
GO:0032815 |
negative regulation of natural killer cell activation(GO:0032815) |
| 0.5 |
3.8 |
GO:0036486 |
trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) |
| 0.5 |
1.4 |
GO:0046947 |
hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
| 0.5 |
0.9 |
GO:0044028 |
DNA hypomethylation(GO:0044028) hypomethylation of CpG island(GO:0044029) |
| 0.5 |
0.5 |
GO:0007219 |
Notch signaling pathway(GO:0007219) |
| 0.5 |
0.9 |
GO:0014707 |
branchiomeric skeletal muscle development(GO:0014707) |
| 0.5 |
1.4 |
GO:0018199 |
peptidyl-glutamine modification(GO:0018199) |
| 0.5 |
1.4 |
GO:0045210 |
FasL biosynthetic process(GO:0045210) |
| 0.5 |
0.5 |
GO:0014735 |
regulation of muscle atrophy(GO:0014735) |
| 0.5 |
11.5 |
GO:0007216 |
G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
| 0.5 |
0.5 |
GO:0010633 |
negative regulation of epithelial cell migration(GO:0010633) |
| 0.5 |
8.3 |
GO:1901750 |
leukotriene D4 metabolic process(GO:1901748) leukotriene D4 biosynthetic process(GO:1901750) |
| 0.5 |
1.4 |
GO:0090187 |
positive regulation of pancreatic juice secretion(GO:0090187) |
| 0.5 |
0.9 |
GO:0005988 |
lactose metabolic process(GO:0005988) lactose biosynthetic process(GO:0005989) |
| 0.5 |
4.6 |
GO:0034465 |
response to carbon monoxide(GO:0034465) |
| 0.5 |
4.1 |
GO:0002329 |
pre-B cell differentiation(GO:0002329) |
| 0.5 |
2.7 |
GO:0060385 |
axonogenesis involved in innervation(GO:0060385) |
| 0.5 |
0.5 |
GO:0045110 |
intermediate filament bundle assembly(GO:0045110) |
| 0.5 |
1.4 |
GO:0045994 |
positive regulation of translational initiation by iron(GO:0045994) |
| 0.4 |
0.4 |
GO:1903378 |
positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
| 0.4 |
1.3 |
GO:0002439 |
chronic inflammatory response to antigenic stimulus(GO:0002439) |
| 0.4 |
0.9 |
GO:0019065 |
receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
| 0.4 |
1.3 |
GO:0090271 |
positive regulation of fibroblast growth factor production(GO:0090271) |
| 0.4 |
1.8 |
GO:0021812 |
neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
| 0.4 |
9.3 |
GO:0071803 |
positive regulation of podosome assembly(GO:0071803) |
| 0.4 |
1.3 |
GO:0000706 |
meiotic DNA double-strand break processing(GO:0000706) |
| 0.4 |
2.6 |
GO:0006003 |
fructose 2,6-bisphosphate metabolic process(GO:0006003) |
| 0.4 |
3.0 |
GO:0007506 |
gonadal mesoderm development(GO:0007506) |
| 0.4 |
6.1 |
GO:0036066 |
protein O-linked fucosylation(GO:0036066) |
| 0.4 |
1.3 |
GO:0046005 |
positive regulation of circadian sleep/wake cycle, REM sleep(GO:0046005) |
| 0.4 |
1.3 |
GO:0042270 |
protection from natural killer cell mediated cytotoxicity(GO:0042270) |
| 0.4 |
1.3 |
GO:1904058 |
positive regulation of sensory perception of pain(GO:1904058) |
| 0.4 |
1.3 |
GO:1903966 |
monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
| 0.4 |
2.5 |
GO:0014028 |
notochord formation(GO:0014028) |
| 0.4 |
0.8 |
GO:0090235 |
regulation of metaphase plate congression(GO:0090235) |
| 0.4 |
0.4 |
GO:0033600 |
negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
| 0.4 |
1.3 |
GO:0051106 |
positive regulation of DNA ligation(GO:0051106) |
| 0.4 |
1.3 |
GO:0019285 |
glycine betaine biosynthetic process from choline(GO:0019285) glycine betaine metabolic process(GO:0031455) glycine betaine biosynthetic process(GO:0031456) |
| 0.4 |
2.1 |
GO:0060356 |
leucine import(GO:0060356) |
| 0.4 |
2.5 |
GO:0010868 |
negative regulation of triglyceride biosynthetic process(GO:0010868) |
| 0.4 |
2.9 |
GO:0060744 |
thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
| 0.4 |
2.1 |
GO:0038169 |
somatostatin receptor signaling pathway(GO:0038169) somatostatin signaling pathway(GO:0038170) |
| 0.4 |
4.1 |
GO:0070813 |
hydrogen sulfide metabolic process(GO:0070813) |
| 0.4 |
2.5 |
GO:0042335 |
cuticle development(GO:0042335) |
| 0.4 |
1.6 |
GO:0042418 |
epinephrine biosynthetic process(GO:0042418) |
| 0.4 |
2.4 |
GO:0010133 |
proline catabolic process to glutamate(GO:0010133) |
| 0.4 |
1.6 |
GO:1902766 |
skeletal muscle satellite cell migration(GO:1902766) |
| 0.4 |
0.8 |
GO:0034141 |
positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
| 0.4 |
1.2 |
GO:0033861 |
negative regulation of NAD(P)H oxidase activity(GO:0033861) |
| 0.4 |
1.6 |
GO:0007198 |
adenylate cyclase-inhibiting serotonin receptor signaling pathway(GO:0007198) |
| 0.4 |
0.4 |
GO:0008355 |
olfactory learning(GO:0008355) |
| 0.4 |
2.0 |
GO:0060054 |
positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
| 0.4 |
0.4 |
GO:0045687 |
positive regulation of glial cell differentiation(GO:0045687) |
| 0.4 |
6.3 |
GO:0043320 |
natural killer cell degranulation(GO:0043320) |
| 0.4 |
1.2 |
GO:0060426 |
lung vasculature development(GO:0060426) |
| 0.4 |
0.4 |
GO:1900195 |
positive regulation of oocyte maturation(GO:1900195) |
| 0.4 |
1.6 |
GO:1900194 |
negative regulation of oocyte maturation(GO:1900194) |
| 0.4 |
1.2 |
GO:0002856 |
negative regulation of response to tumor cell(GO:0002835) negative regulation of immune response to tumor cell(GO:0002838) negative regulation of natural killer cell mediated immune response to tumor cell(GO:0002856) negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002859) cytotoxic T cell degranulation(GO:0043316) regulation of cytotoxic T cell degranulation(GO:0043317) negative regulation of cytotoxic T cell degranulation(GO:0043318) |
| 0.4 |
1.6 |
GO:1902460 |
regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
| 0.4 |
1.6 |
GO:1902613 |
regulation of anti-Mullerian hormone signaling pathway(GO:1902612) negative regulation of anti-Mullerian hormone signaling pathway(GO:1902613) anti-Mullerian hormone signaling pathway(GO:1990262) |
| 0.4 |
1.2 |
GO:0009051 |
pentose-phosphate shunt, oxidative branch(GO:0009051) |
| 0.4 |
1.9 |
GO:0071492 |
cellular response to UV-A(GO:0071492) |
| 0.4 |
3.8 |
GO:0030951 |
establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
| 0.4 |
3.1 |
GO:1902746 |
regulation of lens fiber cell differentiation(GO:1902746) |
| 0.4 |
1.9 |
GO:1990834 |
response to odorant(GO:1990834) |
| 0.4 |
0.4 |
GO:0099638 |
endosome to plasma membrane protein transport(GO:0099638) |
| 0.4 |
1.5 |
GO:2000418 |
positive regulation of eosinophil migration(GO:2000418) |
| 0.4 |
0.8 |
GO:0005985 |
sucrose metabolic process(GO:0005985) |
| 0.4 |
0.8 |
GO:0030886 |
negative regulation of myeloid dendritic cell activation(GO:0030886) |
| 0.4 |
2.3 |
GO:0072675 |
multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
| 0.4 |
1.5 |
GO:1901662 |
phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
| 0.4 |
1.5 |
GO:0042360 |
vitamin E metabolic process(GO:0042360) |
| 0.4 |
0.4 |
GO:0007292 |
female gamete generation(GO:0007292) |
| 0.4 |
4.8 |
GO:0031580 |
membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
| 0.4 |
0.7 |
GO:0001560 |
regulation of cell growth by extracellular stimulus(GO:0001560) |
| 0.4 |
0.4 |
GO:0006789 |
bilirubin conjugation(GO:0006789) |
| 0.4 |
1.5 |
GO:0090038 |
negative regulation of protein kinase C signaling(GO:0090038) |
| 0.4 |
2.9 |
GO:0046836 |
glycolipid transport(GO:0046836) |
| 0.4 |
2.2 |
GO:0060480 |
lung goblet cell differentiation(GO:0060480) |
| 0.4 |
10.5 |
GO:0031581 |
hemidesmosome assembly(GO:0031581) |
| 0.4 |
0.7 |
GO:0032911 |
negative regulation of transforming growth factor beta1 production(GO:0032911) |
| 0.4 |
1.1 |
GO:2000346 |
negative regulation of hepatocyte proliferation(GO:2000346) |
| 0.4 |
0.4 |
GO:0051461 |
positive regulation of corticotropin secretion(GO:0051461) |
| 0.4 |
1.1 |
GO:0048512 |
circadian behavior(GO:0048512) |
| 0.4 |
1.1 |
GO:0035879 |
plasma membrane lactate transport(GO:0035879) |
| 0.4 |
1.4 |
GO:0072344 |
rescue of stalled ribosome(GO:0072344) |
| 0.4 |
1.4 |
GO:1904647 |
response to rotenone(GO:1904647) |
| 0.4 |
1.1 |
GO:0071812 |
regulation of fever generation by regulation of prostaglandin secretion(GO:0071810) positive regulation of fever generation by positive regulation of prostaglandin secretion(GO:0071812) positive regulation of ERK1 and ERK2 cascade via TNFSF11-mediated signaling(GO:0071848) regulation of fever generation by prostaglandin secretion(GO:0100009) |
| 0.3 |
2.1 |
GO:1903715 |
regulation of aerobic respiration(GO:1903715) |
| 0.3 |
2.4 |
GO:0035986 |
senescence-associated heterochromatin focus assembly(GO:0035986) |
| 0.3 |
0.7 |
GO:0021558 |
trochlear nerve development(GO:0021558) |
| 0.3 |
2.4 |
GO:0051122 |
hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
| 0.3 |
1.7 |
GO:1990928 |
response to amino acid starvation(GO:1990928) |
| 0.3 |
1.4 |
GO:0060390 |
regulation of SMAD protein import into nucleus(GO:0060390) |
| 0.3 |
0.7 |
GO:0002268 |
follicular dendritic cell activation(GO:0002266) follicular dendritic cell differentiation(GO:0002268) |
| 0.3 |
0.3 |
GO:2001184 |
positive regulation of interleukin-12 secretion(GO:2001184) |
| 0.3 |
3.4 |
GO:0051918 |
negative regulation of fibrinolysis(GO:0051918) |
| 0.3 |
0.3 |
GO:1903423 |
positive regulation of synaptic vesicle endocytosis(GO:1900244) positive regulation of synaptic vesicle recycling(GO:1903423) |
| 0.3 |
4.4 |
GO:0010991 |
regulation of SMAD protein complex assembly(GO:0010990) negative regulation of SMAD protein complex assembly(GO:0010991) |
| 0.3 |
1.0 |
GO:0070898 |
RNA polymerase III transcriptional preinitiation complex assembly(GO:0070898) |
| 0.3 |
0.7 |
GO:0021798 |
forebrain dorsal/ventral pattern formation(GO:0021798) |
| 0.3 |
0.3 |
GO:0006091 |
generation of precursor metabolites and energy(GO:0006091) |
| 0.3 |
1.3 |
GO:0030311 |
poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
| 0.3 |
1.3 |
GO:1903527 |
positive regulation of membrane tubulation(GO:1903527) |
| 0.3 |
7.7 |
GO:0034380 |
high-density lipoprotein particle assembly(GO:0034380) |
| 0.3 |
1.3 |
GO:1900239 |
phenotypic switching(GO:0036166) metanephric glomerular mesangial cell development(GO:0072255) reversible differentiation(GO:0090677) cell dedifferentiation involved in phenotypic switching(GO:0090678) regulation of phenotypic switching(GO:1900239) positive regulation of phenotypic switching(GO:1900241) regulation of vascular smooth muscle cell dedifferentiation(GO:1905174) positive regulation of vascular smooth muscle cell dedifferentiation(GO:1905176) vascular smooth muscle cell dedifferentiation(GO:1990936) |
| 0.3 |
1.0 |
GO:0060178 |
regulation of exocyst assembly(GO:0001928) regulation of exocyst localization(GO:0060178) |
| 0.3 |
1.0 |
GO:0060166 |
olfactory pit development(GO:0060166) |
| 0.3 |
0.7 |
GO:0045670 |
regulation of osteoclast differentiation(GO:0045670) |
| 0.3 |
1.3 |
GO:0043456 |
regulation of pentose-phosphate shunt(GO:0043456) |
| 0.3 |
1.7 |
GO:0015722 |
canalicular bile acid transport(GO:0015722) |
| 0.3 |
2.7 |
GO:0006868 |
glutamine transport(GO:0006868) |
| 0.3 |
1.0 |
GO:0031630 |
regulation of synaptic vesicle fusion to presynaptic membrane(GO:0031630) |
| 0.3 |
1.3 |
GO:0014054 |
positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
| 0.3 |
7.6 |
GO:1901897 |
regulation of relaxation of cardiac muscle(GO:1901897) |
| 0.3 |
3.0 |
GO:0010940 |
positive regulation of necrotic cell death(GO:0010940) |
| 0.3 |
0.7 |
GO:0048102 |
autophagic cell death(GO:0048102) |
| 0.3 |
1.3 |
GO:0038195 |
urokinase plasminogen activator signaling pathway(GO:0038195) |
| 0.3 |
1.3 |
GO:0033625 |
positive regulation of integrin activation(GO:0033625) |
| 0.3 |
1.3 |
GO:0030728 |
ovulation(GO:0030728) |
| 0.3 |
1.0 |
GO:0010752 |
regulation of cGMP-mediated signaling(GO:0010752) |
| 0.3 |
1.6 |
GO:0033490 |
cholesterol biosynthetic process via desmosterol(GO:0033489) cholesterol biosynthetic process via lathosterol(GO:0033490) |
| 0.3 |
1.3 |
GO:0072268 |
pattern specification involved in metanephros development(GO:0072268) |
| 0.3 |
2.9 |
GO:0007256 |
activation of JNKK activity(GO:0007256) |
| 0.3 |
0.3 |
GO:0051933 |
amino acid neurotransmitter reuptake(GO:0051933) glutamate reuptake(GO:0051935) |
| 0.3 |
1.0 |
GO:1903028 |
positive regulation of opsonization(GO:1903028) |
| 0.3 |
4.8 |
GO:0030949 |
positive regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030949) |
| 0.3 |
0.6 |
GO:0050902 |
leukocyte adhesive activation(GO:0050902) |
| 0.3 |
1.3 |
GO:0019264 |
glycine biosynthetic process from serine(GO:0019264) |
| 0.3 |
4.8 |
GO:1904778 |
regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
| 0.3 |
1.0 |
GO:0006500 |
N-terminal protein palmitoylation(GO:0006500) |
| 0.3 |
1.9 |
GO:0042136 |
neurotransmitter biosynthetic process(GO:0042136) |
| 0.3 |
1.0 |
GO:0003241 |
growth involved in heart morphogenesis(GO:0003241) |
| 0.3 |
0.6 |
GO:0021849 |
neuroblast division in subventricular zone(GO:0021849) |
| 0.3 |
2.2 |
GO:0060992 |
response to fungicide(GO:0060992) |
| 0.3 |
1.6 |
GO:0010609 |
mRNA localization resulting in posttranscriptional regulation of gene expression(GO:0010609) |
| 0.3 |
0.9 |
GO:0098937 |
dendritic transport(GO:0098935) anterograde dendritic transport(GO:0098937) |
| 0.3 |
4.4 |
GO:0051639 |
actin filament network formation(GO:0051639) |
| 0.3 |
4.4 |
GO:0038063 |
collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
| 0.3 |
0.9 |
GO:0019242 |
methylglyoxal biosynthetic process(GO:0019242) |
| 0.3 |
2.5 |
GO:0002315 |
marginal zone B cell differentiation(GO:0002315) |
| 0.3 |
0.3 |
GO:0003419 |
growth plate cartilage chondrocyte proliferation(GO:0003419) |
| 0.3 |
1.2 |
GO:0061146 |
Peyer's patch morphogenesis(GO:0061146) |
| 0.3 |
0.3 |
GO:0015960 |
diadenosine polyphosphate biosynthetic process(GO:0015960) diadenosine tetraphosphate metabolic process(GO:0015965) diadenosine tetraphosphate biosynthetic process(GO:0015966) |
| 0.3 |
1.9 |
GO:0051012 |
microtubule sliding(GO:0051012) |
| 0.3 |
1.5 |
GO:0044565 |
dendritic cell proliferation(GO:0044565) |
| 0.3 |
0.9 |
GO:0048250 |
mitochondrial iron ion transport(GO:0048250) |
| 0.3 |
0.6 |
GO:1901490 |
regulation of lymphangiogenesis(GO:1901490) negative regulation of lymphangiogenesis(GO:1901491) |
| 0.3 |
0.9 |
GO:0002326 |
B cell lineage commitment(GO:0002326) |
| 0.3 |
1.2 |
GO:0006435 |
threonyl-tRNA aminoacylation(GO:0006435) |
| 0.3 |
1.8 |
GO:0090170 |
regulation of Golgi inheritance(GO:0090170) |
| 0.3 |
1.2 |
GO:0050882 |
voluntary musculoskeletal movement(GO:0050882) |
| 0.3 |
2.4 |
GO:0002741 |
positive regulation of cytokine secretion involved in immune response(GO:0002741) |
| 0.3 |
0.6 |
GO:0003215 |
cardiac right ventricle morphogenesis(GO:0003215) |
| 0.3 |
0.9 |
GO:0060574 |
intestinal epithelial cell maturation(GO:0060574) |
| 0.3 |
1.8 |
GO:0007296 |
vitellogenesis(GO:0007296) |
| 0.3 |
0.9 |
GO:1901069 |
guanosine-containing compound catabolic process(GO:1901069) |
| 0.3 |
0.6 |
GO:0021590 |
cerebellum maturation(GO:0021590) cerebellar cortex maturation(GO:0021699) |
| 0.3 |
2.1 |
GO:0006931 |
substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
| 0.3 |
1.5 |
GO:0015862 |
uridine transport(GO:0015862) |
| 0.3 |
0.9 |
GO:0050894 |
determination of affect(GO:0050894) |
| 0.3 |
0.9 |
GO:0021913 |
regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
| 0.3 |
1.5 |
GO:0033274 |
response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
| 0.3 |
1.8 |
GO:0072719 |
cellular response to cisplatin(GO:0072719) |
| 0.3 |
2.1 |
GO:0033623 |
regulation of integrin activation(GO:0033623) |
| 0.3 |
2.3 |
GO:0006452 |
translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
| 0.3 |
0.6 |
GO:1904177 |
regulation of adipose tissue development(GO:1904177) positive regulation of adipose tissue development(GO:1904179) |
| 0.3 |
0.3 |
GO:0050717 |
positive regulation of interleukin-1 alpha secretion(GO:0050717) |
| 0.3 |
0.9 |
GO:0061582 |
intestinal epithelial cell migration(GO:0061582) |
| 0.3 |
0.9 |
GO:0009786 |
regulation of asymmetric cell division(GO:0009786) |
| 0.3 |
1.4 |
GO:0072385 |
minus-end-directed organelle transport along microtubule(GO:0072385) |
| 0.3 |
2.3 |
GO:1900623 |
regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
| 0.3 |
2.9 |
GO:0015014 |
heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
| 0.3 |
1.1 |
GO:0021623 |
optic cup structural organization(GO:0003409) oculomotor nerve development(GO:0021557) oculomotor nerve morphogenesis(GO:0021622) oculomotor nerve formation(GO:0021623) |
| 0.3 |
0.3 |
GO:0045744 |
negative regulation of G-protein coupled receptor protein signaling pathway(GO:0045744) |
| 0.3 |
1.7 |
GO:0032526 |
response to retinoic acid(GO:0032526) |
| 0.3 |
4.3 |
GO:0014041 |
regulation of neuron maturation(GO:0014041) |
| 0.3 |
1.1 |
GO:2000342 |
negative regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000342) |
| 0.3 |
2.3 |
GO:0070197 |
meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
| 0.3 |
0.8 |
GO:1904328 |
regulation of myofibroblast contraction(GO:1904328) myofibroblast contraction(GO:1990764) |
| 0.3 |
0.3 |
GO:0036146 |
cellular response to mycotoxin(GO:0036146) |
| 0.3 |
1.4 |
GO:1904674 |
positive regulation of somatic stem cell population maintenance(GO:1904674) |
| 0.3 |
0.8 |
GO:0002585 |
positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) positive regulation of antigen processing and presentation of peptide antigen(GO:0002585) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) |
| 0.3 |
0.3 |
GO:0010593 |
negative regulation of lamellipodium assembly(GO:0010593) |
| 0.3 |
0.3 |
GO:1902954 |
regulation of early endosome to recycling endosome transport(GO:1902954) |
| 0.3 |
1.4 |
GO:1905098 |
negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
| 0.3 |
1.1 |
GO:0045065 |
cytotoxic T cell differentiation(GO:0045065) |
| 0.3 |
1.1 |
GO:0097350 |
neutrophil clearance(GO:0097350) |
| 0.3 |
1.1 |
GO:2000611 |
positive regulation of thyroid hormone generation(GO:2000611) |
| 0.3 |
0.3 |
GO:0035470 |
positive regulation of vascular wound healing(GO:0035470) |
| 0.3 |
0.8 |
GO:1900220 |
semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
| 0.3 |
1.4 |
GO:1902109 |
negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
| 0.3 |
2.5 |
GO:0060052 |
neurofilament cytoskeleton organization(GO:0060052) |
| 0.3 |
0.3 |
GO:0072709 |
cellular response to sorbitol(GO:0072709) |
| 0.3 |
0.5 |
GO:1901078 |
negative regulation of relaxation of muscle(GO:1901078) |
| 0.3 |
1.1 |
GO:2001287 |
negative regulation of caveolin-mediated endocytosis(GO:2001287) |
| 0.3 |
0.8 |
GO:1903691 |
positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
| 0.3 |
1.1 |
GO:0035811 |
negative regulation of urine volume(GO:0035811) |
| 0.3 |
1.4 |
GO:0071802 |
negative regulation of podosome assembly(GO:0071802) |
| 0.3 |
0.8 |
GO:2001226 |
negative regulation of chloride transport(GO:2001226) |
| 0.3 |
0.8 |
GO:0045062 |
extrathymic T cell selection(GO:0045062) |
| 0.3 |
1.4 |
GO:1900223 |
positive regulation of beta-amyloid clearance(GO:1900223) |
| 0.3 |
5.4 |
GO:2000404 |
regulation of T cell migration(GO:2000404) |
| 0.3 |
0.5 |
GO:0048311 |
mitochondrion distribution(GO:0048311) |
| 0.3 |
0.5 |
GO:0039019 |
pronephric nephron development(GO:0039019) |
| 0.3 |
0.3 |
GO:2001054 |
negative regulation of mesenchymal cell apoptotic process(GO:2001054) |
| 0.3 |
0.5 |
GO:0035774 |
positive regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0035774) |
| 0.3 |
0.8 |
GO:0019287 |
isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
| 0.3 |
1.6 |
GO:0045359 |
positive regulation of interferon-beta biosynthetic process(GO:0045359) |
| 0.3 |
0.5 |
GO:0035963 |
cellular response to interleukin-13(GO:0035963) |
| 0.3 |
1.6 |
GO:0052551 |
response to defense-related nitric oxide production by other organism involved in symbiotic interaction(GO:0052551) response to defense-related host nitric oxide production(GO:0052565) |
| 0.3 |
0.5 |
GO:0030860 |
regulation of polarized epithelial cell differentiation(GO:0030860) |
| 0.3 |
0.8 |
GO:0061001 |
regulation of dendritic spine morphogenesis(GO:0061001) |
| 0.3 |
6.8 |
GO:0007250 |
activation of NF-kappaB-inducing kinase activity(GO:0007250) |
| 0.3 |
2.1 |
GO:1904885 |
beta-catenin destruction complex assembly(GO:1904885) |
| 0.3 |
1.8 |
GO:0002457 |
T cell antigen processing and presentation(GO:0002457) |
| 0.3 |
2.3 |
GO:2000587 |
negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
| 0.3 |
0.8 |
GO:1904717 |
excitatory chemical synaptic transmission(GO:0098976) regulation of AMPA glutamate receptor clustering(GO:1904717) positive regulation of AMPA glutamate receptor clustering(GO:1904719) |
| 0.3 |
2.6 |
GO:1900029 |
positive regulation of ruffle assembly(GO:1900029) |
| 0.3 |
1.0 |
GO:0010579 |
regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
| 0.3 |
1.0 |
GO:0071894 |
histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
| 0.3 |
2.8 |
GO:2000601 |
positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
| 0.3 |
0.3 |
GO:0060988 |
lipid tube assembly(GO:0060988) |
| 0.3 |
2.6 |
GO:0060591 |
chondroblast differentiation(GO:0060591) |
| 0.3 |
0.3 |
GO:1903800 |
regulation of production of small RNA involved in gene silencing by RNA(GO:0070920) regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903798) positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
| 0.3 |
0.8 |
GO:0002678 |
positive regulation of chronic inflammatory response(GO:0002678) |
| 0.3 |
0.3 |
GO:0051604 |
protein maturation(GO:0051604) |
| 0.3 |
1.0 |
GO:0051902 |
negative regulation of mitochondrial depolarization(GO:0051902) |
| 0.3 |
1.5 |
GO:0010642 |
negative regulation of platelet-derived growth factor receptor signaling pathway(GO:0010642) |
| 0.3 |
0.5 |
GO:0019276 |
UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
| 0.3 |
0.5 |
GO:0021898 |
commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) |
| 0.3 |
2.5 |
GO:0051044 |
positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
| 0.3 |
1.8 |
GO:0000389 |
mRNA 3'-splice site recognition(GO:0000389) |
| 0.3 |
0.5 |
GO:0048817 |
negative regulation of hair follicle maturation(GO:0048817) |
| 0.3 |
1.0 |
GO:1900533 |
medium-chain fatty-acyl-CoA catabolic process(GO:0036114) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
| 0.3 |
1.5 |
GO:2000669 |
negative regulation of dendritic cell apoptotic process(GO:2000669) |
| 0.2 |
0.2 |
GO:0001823 |
mesonephros development(GO:0001823) |
| 0.2 |
0.5 |
GO:1904783 |
positive regulation of NMDA glutamate receptor activity(GO:1904783) |
| 0.2 |
0.5 |
GO:0002159 |
desmosome assembly(GO:0002159) |
| 0.2 |
0.5 |
GO:0060699 |
regulation of endoribonuclease activity(GO:0060699) |
| 0.2 |
1.0 |
GO:0035964 |
COPI-coated vesicle budding(GO:0035964) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
| 0.2 |
1.0 |
GO:0044501 |
modulation of signal transduction in other organism(GO:0044501) modulation by symbiont of host signal transduction pathway(GO:0052027) modulation of signal transduction in other organism involved in symbiotic interaction(GO:0052250) modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade(GO:0085032) |
| 0.2 |
6.0 |
GO:0097062 |
dendritic spine maintenance(GO:0097062) |
| 0.2 |
1.0 |
GO:0032484 |
Ral protein signal transduction(GO:0032484) regulation of Ral protein signal transduction(GO:0032485) |
| 0.2 |
0.5 |
GO:0045141 |
meiotic telomere clustering(GO:0045141) |
| 0.2 |
0.7 |
GO:1901873 |
regulation of post-translational protein modification(GO:1901873) |
| 0.2 |
1.0 |
GO:0043504 |
mitochondrial DNA repair(GO:0043504) |
| 0.2 |
1.0 |
GO:0045875 |
negative regulation of sister chromatid cohesion(GO:0045875) |
| 0.2 |
0.2 |
GO:0098828 |
positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
| 0.2 |
2.2 |
GO:0019368 |
fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 0.2 |
1.0 |
GO:0046967 |
cytosol to ER transport(GO:0046967) |
| 0.2 |
2.9 |
GO:0036155 |
acylglycerol acyl-chain remodeling(GO:0036155) |
| 0.2 |
1.7 |
GO:0060017 |
parathyroid gland development(GO:0060017) |
| 0.2 |
1.2 |
GO:0035617 |
stress granule disassembly(GO:0035617) |
| 0.2 |
0.2 |
GO:0002522 |
leukocyte migration involved in immune response(GO:0002522) |
| 0.2 |
0.2 |
GO:0048807 |
female genitalia morphogenesis(GO:0048807) |
| 0.2 |
1.5 |
GO:0006021 |
inositol biosynthetic process(GO:0006021) |
| 0.2 |
1.2 |
GO:0046391 |
5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
| 0.2 |
0.2 |
GO:0071362 |
cellular response to ether(GO:0071362) |
| 0.2 |
1.2 |
GO:0001661 |
conditioned taste aversion(GO:0001661) |
| 0.2 |
0.5 |
GO:2000609 |
regulation of thyroid hormone generation(GO:2000609) |
| 0.2 |
1.4 |
GO:0060586 |
multicellular organismal iron ion homeostasis(GO:0060586) |
| 0.2 |
1.0 |
GO:1900168 |
glial cell-derived neurotrophic factor secretion(GO:0044467) regulation of glial cell-derived neurotrophic factor secretion(GO:1900166) positive regulation of glial cell-derived neurotrophic factor secretion(GO:1900168) |
| 0.2 |
3.3 |
GO:0006002 |
fructose 6-phosphate metabolic process(GO:0006002) |
| 0.2 |
0.2 |
GO:0010845 |
positive regulation of reciprocal meiotic recombination(GO:0010845) |
| 0.2 |
0.2 |
GO:1900084 |
regulation of peptidyl-tyrosine autophosphorylation(GO:1900084) |
| 0.2 |
1.2 |
GO:0038165 |
oncostatin-M-mediated signaling pathway(GO:0038165) |
| 0.2 |
1.2 |
GO:0048570 |
notochord morphogenesis(GO:0048570) |
| 0.2 |
0.5 |
GO:0030497 |
fatty acid elongation(GO:0030497) |
| 0.2 |
1.2 |
GO:2000312 |
regulation of kainate selective glutamate receptor activity(GO:2000312) |
| 0.2 |
0.7 |
GO:0021526 |
medial motor column neuron differentiation(GO:0021526) |
| 0.2 |
0.9 |
GO:0072583 |
clathrin-mediated endocytosis(GO:0072583) |
| 0.2 |
0.5 |
GO:0015798 |
myo-inositol transport(GO:0015798) |
| 0.2 |
0.2 |
GO:1903422 |
negative regulation of synaptic vesicle recycling(GO:1903422) |
| 0.2 |
4.4 |
GO:0030214 |
hyaluronan catabolic process(GO:0030214) |
| 0.2 |
0.2 |
GO:0048537 |
mucosal-associated lymphoid tissue development(GO:0048537) Peyer's patch development(GO:0048541) |
| 0.2 |
1.4 |
GO:0006875 |
cellular metal ion homeostasis(GO:0006875) |
| 0.2 |
0.7 |
GO:0045198 |
establishment of epithelial cell apical/basal polarity(GO:0045198) |
| 0.2 |
1.6 |
GO:0045741 |
positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
| 0.2 |
0.7 |
GO:1902723 |
negative regulation of skeletal muscle cell proliferation(GO:0014859) negative regulation of skeletal muscle satellite cell proliferation(GO:1902723) |
| 0.2 |
0.7 |
GO:0035606 |
peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
| 0.2 |
7.8 |
GO:1904659 |
hexose transmembrane transport(GO:0035428) glucose transmembrane transport(GO:1904659) |
| 0.2 |
0.7 |
GO:0048627 |
myoblast development(GO:0048627) |
| 0.2 |
0.7 |
GO:0042700 |
luteinizing hormone signaling pathway(GO:0042700) cellular response to luteinizing hormone stimulus(GO:0071373) |
| 0.2 |
1.6 |
GO:1902866 |
regulation of retina development in camera-type eye(GO:1902866) |
| 0.2 |
0.9 |
GO:2001151 |
regulation of renal water transport(GO:2001151) positive regulation of renal water transport(GO:2001153) |
| 0.2 |
2.0 |
GO:0032776 |
DNA methylation on cytosine(GO:0032776) |
| 0.2 |
0.5 |
GO:0002580 |
regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002580) |
| 0.2 |
6.6 |
GO:0045746 |
negative regulation of Notch signaling pathway(GO:0045746) |
| 0.2 |
0.7 |
GO:0006427 |
histidyl-tRNA aminoacylation(GO:0006427) |
| 0.2 |
0.7 |
GO:0060370 |
susceptibility to T cell mediated cytotoxicity(GO:0060370) |
| 0.2 |
1.8 |
GO:1904627 |
response to phorbol 13-acetate 12-myristate(GO:1904627) cellular response to phorbol 13-acetate 12-myristate(GO:1904628) |
| 0.2 |
3.4 |
GO:0034063 |
stress granule assembly(GO:0034063) |
| 0.2 |
7.2 |
GO:0035767 |
endothelial cell chemotaxis(GO:0035767) |
| 0.2 |
0.4 |
GO:0035672 |
oligopeptide transmembrane transport(GO:0035672) |
| 0.2 |
0.7 |
GO:0031660 |
regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031660) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031662) response to DDT(GO:0046680) histone H3-S10 phosphorylation involved in chromosome condensation(GO:2000775) |
| 0.2 |
2.2 |
GO:2001224 |
positive regulation of neuron migration(GO:2001224) |
| 0.2 |
0.2 |
GO:2000765 |
regulation of cytoplasmic translation(GO:2000765) negative regulation of cytoplasmic translation(GO:2000766) |
| 0.2 |
1.3 |
GO:1904781 |
positive regulation of protein localization to centrosome(GO:1904781) |
| 0.2 |
1.8 |
GO:0042760 |
very long-chain fatty acid catabolic process(GO:0042760) |
| 0.2 |
0.2 |
GO:0048320 |
axial mesoderm formation(GO:0048320) |
| 0.2 |
0.2 |
GO:0051195 |
negative regulation of glycolytic process(GO:0045820) negative regulation of cofactor metabolic process(GO:0051195) negative regulation of coenzyme metabolic process(GO:0051198) |
| 0.2 |
2.0 |
GO:0010839 |
negative regulation of keratinocyte proliferation(GO:0010839) |
| 0.2 |
0.2 |
GO:1905232 |
cellular response to L-glutamate(GO:1905232) |
| 0.2 |
0.7 |
GO:0044376 |
RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
| 0.2 |
0.7 |
GO:0097527 |
necroptotic signaling pathway(GO:0097527) |
| 0.2 |
0.4 |
GO:0042771 |
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
| 0.2 |
1.1 |
GO:1904274 |
tricellular tight junction assembly(GO:1904274) |
| 0.2 |
1.1 |
GO:2001271 |
negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
| 0.2 |
0.2 |
GO:0043353 |
enucleate erythrocyte differentiation(GO:0043353) |
| 0.2 |
1.1 |
GO:0042631 |
cellular response to water deprivation(GO:0042631) |
| 0.2 |
0.4 |
GO:1904504 |
regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
| 0.2 |
1.7 |
GO:0030903 |
notochord development(GO:0030903) |
| 0.2 |
1.1 |
GO:0090205 |
positive regulation of cholesterol metabolic process(GO:0090205) |
| 0.2 |
0.2 |
GO:1900122 |
positive regulation of receptor binding(GO:1900122) |
| 0.2 |
0.6 |
GO:0042759 |
long-chain fatty acid biosynthetic process(GO:0042759) |
| 0.2 |
0.9 |
GO:0038003 |
opioid receptor signaling pathway(GO:0038003) |
| 0.2 |
0.9 |
GO:0090158 |
endoplasmic reticulum membrane organization(GO:0090158) |
| 0.2 |
1.1 |
GO:0071051 |
polyadenylation-dependent snoRNA 3'-end processing(GO:0071051) |
| 0.2 |
0.2 |
GO:0016071 |
mRNA metabolic process(GO:0016071) |
| 0.2 |
0.9 |
GO:0042853 |
L-alanine metabolic process(GO:0042851) L-alanine catabolic process(GO:0042853) |
| 0.2 |
6.0 |
GO:0032332 |
positive regulation of chondrocyte differentiation(GO:0032332) |
| 0.2 |
0.6 |
GO:0001172 |
transcription, RNA-templated(GO:0001172) |
| 0.2 |
1.3 |
GO:0070141 |
response to UV-A(GO:0070141) |
| 0.2 |
3.0 |
GO:0015816 |
glycine transport(GO:0015816) |
| 0.2 |
0.2 |
GO:0003099 |
regulation of the force of heart contraction by chemical signal(GO:0003057) positive regulation of the force of heart contraction by chemical signal(GO:0003099) |
| 0.2 |
3.6 |
GO:0019371 |
cyclooxygenase pathway(GO:0019371) |
| 0.2 |
0.6 |
GO:0060215 |
primitive hemopoiesis(GO:0060215) |
| 0.2 |
0.6 |
GO:0036512 |
trimming of terminal mannose on B branch(GO:0036509) trimming of first mannose on A branch(GO:0036511) trimming of second mannose on A branch(GO:0036512) |
| 0.2 |
1.1 |
GO:1904217 |
regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 0.2 |
2.8 |
GO:0042178 |
xenobiotic catabolic process(GO:0042178) |
| 0.2 |
1.1 |
GO:0044571 |
[2Fe-2S] cluster assembly(GO:0044571) |
| 0.2 |
0.2 |
GO:2001223 |
negative regulation of neuron migration(GO:2001223) |
| 0.2 |
0.6 |
GO:0000290 |
deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
| 0.2 |
1.0 |
GO:2000370 |
positive regulation of clathrin-mediated endocytosis(GO:2000370) |
| 0.2 |
1.0 |
GO:0006438 |
valyl-tRNA aminoacylation(GO:0006438) |
| 0.2 |
1.0 |
GO:0071649 |
regulation of chemokine (C-C motif) ligand 5 production(GO:0071649) |
| 0.2 |
2.5 |
GO:0032495 |
response to muramyl dipeptide(GO:0032495) |
| 0.2 |
2.1 |
GO:0044351 |
macropinocytosis(GO:0044351) |
| 0.2 |
1.9 |
GO:0030043 |
actin filament fragmentation(GO:0030043) |
| 0.2 |
0.8 |
GO:0035616 |
histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
| 0.2 |
1.2 |
GO:0006177 |
GMP biosynthetic process(GO:0006177) |
| 0.2 |
0.4 |
GO:0021966 |
corticospinal neuron axon guidance(GO:0021966) |
| 0.2 |
3.7 |
GO:2001197 |
regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
| 0.2 |
0.4 |
GO:0016999 |
antibiotic metabolic process(GO:0016999) |
| 0.2 |
0.4 |
GO:0015783 |
GDP-fucose transport(GO:0015783) purine nucleotide-sugar transport(GO:0036079) |
| 0.2 |
3.9 |
GO:0034656 |
nucleobase-containing small molecule catabolic process(GO:0034656) |
| 0.2 |
0.8 |
GO:0030718 |
germ-line stem cell population maintenance(GO:0030718) |
| 0.2 |
1.0 |
GO:0002767 |
immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
| 0.2 |
0.4 |
GO:0002541 |
activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
| 0.2 |
1.0 |
GO:0030578 |
PML body organization(GO:0030578) |
| 0.2 |
0.2 |
GO:1903351 |
response to dopamine(GO:1903350) cellular response to dopamine(GO:1903351) |
| 0.2 |
1.2 |
GO:0043651 |
linoleic acid metabolic process(GO:0043651) |
| 0.2 |
1.4 |
GO:1900262 |
regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 0.2 |
0.8 |
GO:0033031 |
positive regulation of neutrophil apoptotic process(GO:0033031) |
| 0.2 |
1.0 |
GO:0010887 |
negative regulation of cholesterol storage(GO:0010887) |
| 0.2 |
1.6 |
GO:0017085 |
response to insecticide(GO:0017085) |
| 0.2 |
0.6 |
GO:0006597 |
spermine biosynthetic process(GO:0006597) |
| 0.2 |
0.2 |
GO:0060068 |
vagina development(GO:0060068) |
| 0.2 |
0.6 |
GO:0090149 |
mitochondrial membrane fission(GO:0090149) |
| 0.2 |
2.6 |
GO:0071711 |
basement membrane organization(GO:0071711) |
| 0.2 |
0.6 |
GO:0009730 |
detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
| 0.2 |
0.2 |
GO:0032707 |
negative regulation of interleukin-23 production(GO:0032707) |
| 0.2 |
0.6 |
GO:0040010 |
positive regulation of growth rate(GO:0040010) regulation of gastric mucosal blood circulation(GO:1904344) positive regulation of gastric mucosal blood circulation(GO:1904346) gastric mucosal blood circulation(GO:1990768) |
| 0.2 |
2.2 |
GO:0017183 |
peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
| 0.2 |
2.4 |
GO:1901070 |
guanosine-containing compound biosynthetic process(GO:1901070) |
| 0.2 |
0.2 |
GO:1990737 |
response to manganese-induced endoplasmic reticulum stress(GO:1990737) |
| 0.2 |
1.4 |
GO:0097084 |
vascular smooth muscle cell development(GO:0097084) |
| 0.2 |
1.0 |
GO:0015015 |
heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
| 0.2 |
0.2 |
GO:0035434 |
copper ion transmembrane transport(GO:0035434) |
| 0.2 |
0.4 |
GO:0035634 |
response to stilbenoid(GO:0035634) |
| 0.2 |
3.3 |
GO:0060445 |
branching involved in salivary gland morphogenesis(GO:0060445) |
| 0.2 |
0.2 |
GO:0055069 |
zinc ion homeostasis(GO:0055069) |
| 0.2 |
0.8 |
GO:1990910 |
response to hypobaric hypoxia(GO:1990910) |
| 0.2 |
0.6 |
GO:0021796 |
cerebral cortex regionalization(GO:0021796) |
| 0.2 |
1.2 |
GO:0051534 |
negative regulation of NFAT protein import into nucleus(GO:0051534) |
| 0.2 |
0.4 |
GO:1902474 |
positive regulation of protein localization to synapse(GO:1902474) |
| 0.2 |
1.3 |
GO:0010898 |
positive regulation of triglyceride catabolic process(GO:0010898) |
| 0.2 |
0.2 |
GO:0018171 |
peptidyl-cysteine oxidation(GO:0018171) |
| 0.2 |
0.6 |
GO:1990927 |
calcium ion regulated lysosome exocytosis(GO:1990927) |
| 0.2 |
0.8 |
GO:0015824 |
proline transport(GO:0015824) proline transmembrane transport(GO:0035524) |
| 0.2 |
1.5 |
GO:0051546 |
keratinocyte migration(GO:0051546) |
| 0.2 |
2.1 |
GO:0042670 |
retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
| 0.2 |
0.8 |
GO:0003335 |
corneocyte development(GO:0003335) |
| 0.2 |
0.8 |
GO:0000432 |
regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) |
| 0.2 |
1.7 |
GO:0070315 |
G1 to G0 transition involved in cell differentiation(GO:0070315) |
| 0.2 |
4.8 |
GO:0001829 |
trophectodermal cell differentiation(GO:0001829) |
| 0.2 |
2.9 |
GO:0006907 |
pinocytosis(GO:0006907) |
| 0.2 |
0.4 |
GO:0060065 |
uterus development(GO:0060065) |
| 0.2 |
0.6 |
GO:0021965 |
spinal cord ventral commissure morphogenesis(GO:0021965) |
| 0.2 |
0.8 |
GO:0017198 |
N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
| 0.2 |
0.8 |
GO:0019401 |
alditol biosynthetic process(GO:0019401) |
| 0.2 |
1.9 |
GO:0045721 |
negative regulation of gluconeogenesis(GO:0045721) |
| 0.2 |
0.6 |
GO:0009111 |
vitamin catabolic process(GO:0009111) |
| 0.2 |
0.6 |
GO:0001732 |
formation of cytoplasmic translation initiation complex(GO:0001732) |
| 0.2 |
0.4 |
GO:0046051 |
UTP metabolic process(GO:0046051) |
| 0.2 |
1.5 |
GO:1901525 |
negative regulation of macromitophagy(GO:1901525) |
| 0.2 |
1.5 |
GO:0042167 |
porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
| 0.2 |
1.9 |
GO:0032510 |
endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
| 0.2 |
0.4 |
GO:1900451 |
positive regulation of glutamate receptor signaling pathway(GO:1900451) |
| 0.2 |
0.6 |
GO:0043473 |
pigmentation(GO:0043473) |
| 0.2 |
1.3 |
GO:2001137 |
positive regulation of endocytic recycling(GO:2001137) |
| 0.2 |
1.3 |
GO:0090336 |
positive regulation of brown fat cell differentiation(GO:0090336) |
| 0.2 |
0.6 |
GO:0002934 |
desmosome organization(GO:0002934) |
| 0.2 |
0.2 |
GO:2000049 |
positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
| 0.2 |
0.2 |
GO:0032754 |
positive regulation of interleukin-5 production(GO:0032754) |
| 0.2 |
1.8 |
GO:0031584 |
activation of phospholipase D activity(GO:0031584) |
| 0.2 |
0.6 |
GO:0071034 |
CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
| 0.2 |
1.1 |
GO:1990000 |
amyloid fibril formation(GO:1990000) |
| 0.2 |
1.5 |
GO:0032287 |
peripheral nervous system myelin maintenance(GO:0032287) |
| 0.2 |
0.5 |
GO:1901631 |
positive regulation of presynaptic membrane organization(GO:1901631) |
| 0.2 |
1.1 |
GO:0060020 |
Bergmann glial cell differentiation(GO:0060020) |
| 0.2 |
1.8 |
GO:0006686 |
sphingomyelin biosynthetic process(GO:0006686) |
| 0.2 |
0.4 |
GO:0014003 |
oligodendrocyte development(GO:0014003) |
| 0.2 |
0.4 |
GO:0032417 |
positive regulation of sodium:proton antiporter activity(GO:0032417) |
| 0.2 |
0.2 |
GO:1903862 |
positive regulation of oxidative phosphorylation(GO:1903862) |
| 0.2 |
0.7 |
GO:0010767 |
regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage(GO:0010767) |
| 0.2 |
0.5 |
GO:0015680 |
intracellular copper ion transport(GO:0015680) |
| 0.2 |
0.9 |
GO:0010591 |
regulation of lamellipodium assembly(GO:0010591) |
| 0.2 |
0.4 |
GO:2000182 |
regulation of progesterone biosynthetic process(GO:2000182) |
| 0.2 |
0.4 |
GO:2000286 |
receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
| 0.2 |
0.2 |
GO:0001710 |
mesodermal cell fate commitment(GO:0001710) |
| 0.2 |
0.4 |
GO:0061056 |
sclerotome development(GO:0061056) |
| 0.2 |
2.2 |
GO:0070389 |
chaperone cofactor-dependent protein refolding(GO:0070389) |
| 0.2 |
1.6 |
GO:2000786 |
positive regulation of autophagosome assembly(GO:2000786) |
| 0.2 |
1.3 |
GO:0021842 |
directional guidance of interneurons involved in migration from the subpallium to the cortex(GO:0021840) chemorepulsion involved in interneuron migration from the subpallium to the cortex(GO:0021842) |
| 0.2 |
3.6 |
GO:0034199 |
activation of protein kinase A activity(GO:0034199) |
| 0.2 |
0.9 |
GO:0086046 |
membrane depolarization during SA node cell action potential(GO:0086046) |
| 0.2 |
1.1 |
GO:0014051 |
gamma-aminobutyric acid secretion(GO:0014051) |
| 0.2 |
0.2 |
GO:1903903 |
regulation of establishment of T cell polarity(GO:1903903) |
| 0.2 |
0.2 |
GO:0042662 |
negative regulation of mesodermal cell fate specification(GO:0042662) |
| 0.2 |
0.5 |
GO:0038098 |
sequestering of BMP from receptor via BMP binding(GO:0038098) |
| 0.2 |
0.2 |
GO:0071680 |
response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
| 0.2 |
0.5 |
GO:1900073 |
regulation of neuromuscular synaptic transmission(GO:1900073) positive regulation of neuromuscular synaptic transmission(GO:1900075) |
| 0.2 |
0.7 |
GO:0070945 |
neutrophil mediated killing of gram-negative bacterium(GO:0070945) |
| 0.2 |
1.0 |
GO:0006636 |
unsaturated fatty acid biosynthetic process(GO:0006636) |
| 0.2 |
0.7 |
GO:0030817 |
regulation of cAMP biosynthetic process(GO:0030817) |
| 0.2 |
0.3 |
GO:2000820 |
negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000820) |
| 0.2 |
0.5 |
GO:0044828 |
negative regulation by host of viral genome replication(GO:0044828) |
| 0.2 |
0.5 |
GO:0030948 |
negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
| 0.2 |
0.5 |
GO:0048631 |
regulation of skeletal muscle tissue growth(GO:0048631) |
| 0.2 |
0.5 |
GO:0061386 |
closure of optic fissure(GO:0061386) |
| 0.2 |
1.2 |
GO:0007168 |
receptor guanylyl cyclase signaling pathway(GO:0007168) |
| 0.2 |
0.5 |
GO:0098707 |
ferrous iron import(GO:0070627) ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) |
| 0.2 |
1.7 |
GO:0033227 |
dsRNA transport(GO:0033227) |
| 0.2 |
0.3 |
GO:0006290 |
pyrimidine dimer repair(GO:0006290) |
| 0.2 |
1.9 |
GO:0035279 |
mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
| 0.2 |
0.3 |
GO:0042420 |
dopamine catabolic process(GO:0042420) |
| 0.2 |
0.2 |
GO:0072289 |
metanephric nephron tubule formation(GO:0072289) |
| 0.2 |
1.2 |
GO:0007144 |
female meiosis I(GO:0007144) |
| 0.2 |
1.2 |
GO:0032926 |
negative regulation of activin receptor signaling pathway(GO:0032926) |
| 0.2 |
2.0 |
GO:0045109 |
intermediate filament organization(GO:0045109) |
| 0.2 |
1.0 |
GO:0001955 |
blood vessel maturation(GO:0001955) |
| 0.2 |
1.2 |
GO:0090050 |
positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
| 0.2 |
1.0 |
GO:1901908 |
diadenosine polyphosphate metabolic process(GO:0015959) diadenosine polyphosphate catabolic process(GO:0015961) diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
| 0.2 |
1.2 |
GO:1903232 |
melanosome assembly(GO:1903232) |
| 0.2 |
0.3 |
GO:0003358 |
noradrenergic neuron development(GO:0003358) |
| 0.2 |
0.5 |
GO:0097051 |
establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
| 0.2 |
4.3 |
GO:0048268 |
clathrin coat assembly(GO:0048268) |
| 0.2 |
4.0 |
GO:0060334 |
regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
| 0.2 |
0.2 |
GO:0009439 |
cyanate metabolic process(GO:0009439) cyanate catabolic process(GO:0009440) |
| 0.2 |
1.0 |
GO:0010726 |
positive regulation of hydrogen peroxide metabolic process(GO:0010726) |
| 0.2 |
0.3 |
GO:1904469 |
positive regulation of tumor necrosis factor secretion(GO:1904469) tumor necrosis factor secretion(GO:1990774) |
| 0.2 |
1.0 |
GO:0006878 |
cellular copper ion homeostasis(GO:0006878) |
| 0.2 |
0.3 |
GO:0042756 |
drinking behavior(GO:0042756) |
| 0.2 |
1.3 |
GO:0046618 |
drug export(GO:0046618) |
| 0.2 |
0.7 |
GO:0048266 |
behavioral response to pain(GO:0048266) |
| 0.2 |
0.3 |
GO:1904098 |
regulation of protein O-linked glycosylation(GO:1904098) positive regulation of protein O-linked glycosylation(GO:1904100) |
| 0.2 |
0.2 |
GO:0032640 |
tumor necrosis factor production(GO:0032640) regulation of tumor necrosis factor production(GO:0032680) |
| 0.2 |
0.3 |
GO:0032679 |
TRAIL production(GO:0032639) regulation of TRAIL production(GO:0032679) positive regulation of TRAIL production(GO:0032759) |
| 0.2 |
0.2 |
GO:0032627 |
interleukin-23 production(GO:0032627) regulation of interleukin-23 production(GO:0032667) |
| 0.2 |
0.8 |
GO:0007070 |
negative regulation of transcription during mitosis(GO:0007068) negative regulation of transcription from RNA polymerase II promoter during mitosis(GO:0007070) |
| 0.2 |
0.3 |
GO:0007412 |
axon target recognition(GO:0007412) |
| 0.2 |
0.3 |
GO:0000050 |
urea cycle(GO:0000050) |
| 0.2 |
0.5 |
GO:0042450 |
arginine biosynthetic process via ornithine(GO:0042450) |
| 0.2 |
0.3 |
GO:0001954 |
positive regulation of cell-matrix adhesion(GO:0001954) |
| 0.2 |
1.0 |
GO:0006287 |
base-excision repair, gap-filling(GO:0006287) |
| 0.2 |
1.0 |
GO:0046398 |
UDP-glucuronate biosynthetic process(GO:0006065) UDP-glucuronate metabolic process(GO:0046398) |
| 0.2 |
0.6 |
GO:2000348 |
regulation of CD40 signaling pathway(GO:2000348) |
| 0.2 |
1.9 |
GO:2000010 |
positive regulation of protein localization to cell surface(GO:2000010) |
| 0.2 |
0.2 |
GO:2000506 |
negative regulation of energy homeostasis(GO:2000506) |
| 0.2 |
1.8 |
GO:0001778 |
plasma membrane repair(GO:0001778) |
| 0.2 |
4.0 |
GO:0006646 |
phosphatidylethanolamine biosynthetic process(GO:0006646) |
| 0.2 |
0.8 |
GO:0090131 |
mesenchyme migration(GO:0090131) |
| 0.2 |
0.2 |
GO:0030432 |
peristalsis(GO:0030432) |
| 0.2 |
0.8 |
GO:0035814 |
negative regulation of renal sodium excretion(GO:0035814) |
| 0.2 |
0.6 |
GO:0060478 |
acrosomal vesicle exocytosis(GO:0060478) |
| 0.2 |
0.3 |
GO:0072069 |
DCT cell differentiation(GO:0072069) metanephric DCT cell differentiation(GO:0072240) |
| 0.2 |
1.9 |
GO:0098789 |
pre-mRNA cleavage required for polyadenylation(GO:0098789) |
| 0.2 |
1.3 |
GO:1903764 |
regulation of potassium ion export across plasma membrane(GO:1903764) |
| 0.2 |
0.9 |
GO:2000323 |
negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
| 0.2 |
0.2 |
GO:0060037 |
pharyngeal system development(GO:0060037) |
| 0.2 |
0.8 |
GO:0050917 |
sensory perception of umami taste(GO:0050917) |
| 0.2 |
0.3 |
GO:0001994 |
norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
| 0.2 |
0.9 |
GO:0010666 |
positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
| 0.2 |
0.5 |
GO:0046294 |
formaldehyde catabolic process(GO:0046294) |
| 0.2 |
0.6 |
GO:0046909 |
intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
| 0.2 |
0.2 |
GO:0038092 |
nodal signaling pathway(GO:0038092) |
| 0.2 |
0.3 |
GO:0038026 |
reelin-mediated signaling pathway(GO:0038026) |
| 0.2 |
0.9 |
GO:0090037 |
positive regulation of protein kinase C signaling(GO:0090037) |
| 0.2 |
0.2 |
GO:0061034 |
olfactory bulb mitral cell layer development(GO:0061034) |
| 0.2 |
0.5 |
GO:0071321 |
cellular response to cGMP(GO:0071321) |
| 0.2 |
0.6 |
GO:0044878 |
mitotic cytokinesis checkpoint(GO:0044878) |
| 0.2 |
0.5 |
GO:0048318 |
axial mesoderm development(GO:0048318) |
| 0.2 |
0.5 |
GO:0021979 |
hypothalamus cell differentiation(GO:0021979) |
| 0.2 |
0.2 |
GO:1902219 |
negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
| 0.2 |
1.4 |
GO:0030299 |
intestinal cholesterol absorption(GO:0030299) intestinal lipid absorption(GO:0098856) |
| 0.2 |
0.5 |
GO:0051685 |
maintenance of ER location(GO:0051685) |
| 0.2 |
0.8 |
GO:0061687 |
detoxification of copper ion(GO:0010273) detoxification of inorganic compound(GO:0061687) stress response to copper ion(GO:1990169) |
| 0.2 |
0.3 |
GO:0046826 |
negative regulation of protein export from nucleus(GO:0046826) |
| 0.2 |
2.1 |
GO:0035970 |
peptidyl-threonine dephosphorylation(GO:0035970) |
| 0.2 |
2.4 |
GO:0071318 |
cellular response to ATP(GO:0071318) |
| 0.2 |
1.2 |
GO:0045078 |
positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
| 0.2 |
0.2 |
GO:0045014 |
carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
| 0.2 |
0.5 |
GO:0044210 |
'de novo' CTP biosynthetic process(GO:0044210) |
| 0.2 |
0.5 |
GO:0060266 |
negative regulation of respiratory burst involved in inflammatory response(GO:0060266) |
| 0.2 |
0.8 |
GO:0002175 |
protein localization to paranode region of axon(GO:0002175) |
| 0.2 |
1.7 |
GO:0015712 |
hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.2 |
1.7 |
GO:0021942 |
radial glia guided migration of Purkinje cell(GO:0021942) |
| 0.1 |
3.4 |
GO:1901685 |
glutathione derivative metabolic process(GO:1901685) glutathione derivative biosynthetic process(GO:1901687) |
| 0.1 |
1.2 |
GO:1903054 |
negative regulation of extracellular matrix organization(GO:1903054) |
| 0.1 |
0.4 |
GO:0035526 |
retrograde transport, plasma membrane to Golgi(GO:0035526) |
| 0.1 |
0.3 |
GO:1901857 |
positive regulation of cellular respiration(GO:1901857) |
| 0.1 |
0.4 |
GO:1904604 |
regulation of connective tissue replacement involved in inflammatory response wound healing(GO:1904596) negative regulation of connective tissue replacement involved in inflammatory response wound healing(GO:1904597) regulation of advanced glycation end-product receptor activity(GO:1904603) negative regulation of advanced glycation end-product receptor activity(GO:1904604) negative regulation of connective tissue replacement(GO:1905204) |
| 0.1 |
2.4 |
GO:0007172 |
signal complex assembly(GO:0007172) |
| 0.1 |
0.4 |
GO:0021521 |
ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
| 0.1 |
0.4 |
GO:0071442 |
positive regulation of histone H3-K14 acetylation(GO:0071442) |
| 0.1 |
0.3 |
GO:0098759 |
response to interleukin-8(GO:0098758) cellular response to interleukin-8(GO:0098759) |
| 0.1 |
0.1 |
GO:0003162 |
atrioventricular node development(GO:0003162) |
| 0.1 |
1.0 |
GO:0031274 |
pseudopodium assembly(GO:0031269) regulation of pseudopodium assembly(GO:0031272) positive regulation of pseudopodium assembly(GO:0031274) |
| 0.1 |
5.4 |
GO:0018146 |
keratan sulfate biosynthetic process(GO:0018146) |
| 0.1 |
1.5 |
GO:0003376 |
sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
| 0.1 |
0.6 |
GO:0035425 |
autocrine signaling(GO:0035425) |
| 0.1 |
2.9 |
GO:0071447 |
cellular response to hydroperoxide(GO:0071447) |
| 0.1 |
1.7 |
GO:1904714 |
regulation of chaperone-mediated autophagy(GO:1904714) |
| 0.1 |
1.0 |
GO:1902915 |
negative regulation of histone ubiquitination(GO:0033183) negative regulation of protein K63-linked ubiquitination(GO:1900045) regulation of histone H2A K63-linked ubiquitination(GO:1901314) negative regulation of histone H2A K63-linked ubiquitination(GO:1901315) negative regulation of protein polyubiquitination(GO:1902915) |
| 0.1 |
0.1 |
GO:0060012 |
synaptic transmission, glycinergic(GO:0060012) |
| 0.1 |
0.1 |
GO:0071451 |
response to superoxide(GO:0000303) cellular response to oxygen radical(GO:0071450) cellular response to superoxide(GO:0071451) |
| 0.1 |
0.6 |
GO:0071469 |
cellular response to alkaline pH(GO:0071469) |
| 0.1 |
1.0 |
GO:0021859 |
pyramidal neuron differentiation(GO:0021859) pyramidal neuron development(GO:0021860) |
| 0.1 |
0.3 |
GO:1903225 |
negative regulation of endodermal cell differentiation(GO:1903225) |
| 0.1 |
0.4 |
GO:1903553 |
positive regulation of extracellular exosome assembly(GO:1903553) |
| 0.1 |
0.6 |
GO:1903412 |
response to bile acid(GO:1903412) |
| 0.1 |
0.9 |
GO:0006574 |
valine catabolic process(GO:0006574) |
| 0.1 |
0.3 |
GO:0051665 |
membrane raft localization(GO:0051665) |
| 0.1 |
1.3 |
GO:0045039 |
protein import into mitochondrial inner membrane(GO:0045039) |
| 0.1 |
1.3 |
GO:0019227 |
neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
| 0.1 |
2.8 |
GO:0036150 |
phosphatidylserine acyl-chain remodeling(GO:0036150) |
| 0.1 |
0.6 |
GO:0048703 |
embryonic viscerocranium morphogenesis(GO:0048703) |
| 0.1 |
0.7 |
GO:0030241 |
skeletal muscle myosin thick filament assembly(GO:0030241) |
| 0.1 |
0.3 |
GO:0051799 |
negative regulation of hair follicle development(GO:0051799) |
| 0.1 |
0.7 |
GO:1900383 |
regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
| 0.1 |
1.1 |
GO:0045048 |
protein insertion into ER membrane(GO:0045048) |
| 0.1 |
1.7 |
GO:0033622 |
integrin activation(GO:0033622) |
| 0.1 |
0.8 |
GO:0043653 |
mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
| 0.1 |
0.4 |
GO:0021957 |
corticospinal tract morphogenesis(GO:0021957) |
| 0.1 |
0.4 |
GO:0035022 |
positive regulation of Rac protein signal transduction(GO:0035022) |
| 0.1 |
0.4 |
GO:1901052 |
sarcosine metabolic process(GO:1901052) sarcosine catabolic process(GO:1901053) |
| 0.1 |
0.4 |
GO:0090324 |
negative regulation of oxidative phosphorylation(GO:0090324) |
| 0.1 |
1.7 |
GO:0043951 |
negative regulation of cAMP-mediated signaling(GO:0043951) |
| 0.1 |
1.7 |
GO:0048026 |
positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
| 0.1 |
2.8 |
GO:2000300 |
regulation of synaptic vesicle exocytosis(GO:2000300) |
| 0.1 |
0.4 |
GO:0060441 |
epithelial tube branching involved in lung morphogenesis(GO:0060441) |
| 0.1 |
0.3 |
GO:0032096 |
negative regulation of response to food(GO:0032096) negative regulation of appetite(GO:0032099) |
| 0.1 |
1.0 |
GO:0051026 |
chiasma assembly(GO:0051026) |
| 0.1 |
5.6 |
GO:0045776 |
negative regulation of blood pressure(GO:0045776) |
| 0.1 |
0.8 |
GO:0045598 |
regulation of fat cell differentiation(GO:0045598) |
| 0.1 |
5.6 |
GO:0050690 |
regulation of defense response to virus by virus(GO:0050690) |
| 0.1 |
0.4 |
GO:0009298 |
GDP-mannose biosynthetic process(GO:0009298) |
| 0.1 |
1.9 |
GO:0006610 |
ribosomal protein import into nucleus(GO:0006610) |
| 0.1 |
3.4 |
GO:0033540 |
fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
| 0.1 |
0.9 |
GO:0090009 |
primitive streak formation(GO:0090009) |
| 0.1 |
2.8 |
GO:0000185 |
activation of MAPKKK activity(GO:0000185) |
| 0.1 |
0.3 |
GO:0060672 |
epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
| 0.1 |
0.3 |
GO:0021569 |
rhombomere 3 development(GO:0021569) |
| 0.1 |
1.1 |
GO:0048853 |
forebrain morphogenesis(GO:0048853) |
| 0.1 |
0.8 |
GO:0009082 |
branched-chain amino acid biosynthetic process(GO:0009082) leucine biosynthetic process(GO:0009098) valine biosynthetic process(GO:0009099) |
| 0.1 |
0.4 |
GO:1904404 |
transcription factor catabolic process(GO:0036369) cellular response to vitamin B1(GO:0071301) response to formaldehyde(GO:1904404) |
| 0.1 |
0.4 |
GO:0006423 |
cysteinyl-tRNA aminoacylation(GO:0006423) |
| 0.1 |
0.4 |
GO:0046900 |
tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
| 0.1 |
1.3 |
GO:0034214 |
protein hexamerization(GO:0034214) |
| 0.1 |
0.5 |
GO:1905123 |
regulation of endosome organization(GO:1904978) regulation of glucosylceramidase activity(GO:1905123) |
| 0.1 |
0.7 |
GO:0002318 |
myeloid progenitor cell differentiation(GO:0002318) |
| 0.1 |
0.1 |
GO:0070459 |
prolactin secretion(GO:0070459) |
| 0.1 |
0.7 |
GO:1904338 |
regulation of dopaminergic neuron differentiation(GO:1904338) |
| 0.1 |
2.0 |
GO:0032968 |
positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
| 0.1 |
0.7 |
GO:0070508 |
sterol import(GO:0035376) cholesterol import(GO:0070508) |
| 0.1 |
0.7 |
GO:0048749 |
compound eye development(GO:0048749) |
| 0.1 |
0.1 |
GO:2000157 |
regulation of protein K48-linked deubiquitination(GO:1903093) negative regulation of protein K48-linked deubiquitination(GO:1903094) negative regulation of ubiquitin-specific protease activity(GO:2000157) |
| 0.1 |
0.9 |
GO:1902043 |
positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
| 0.1 |
0.9 |
GO:0031914 |
negative regulation of synaptic plasticity(GO:0031914) |
| 0.1 |
0.8 |
GO:0051684 |
maintenance of Golgi location(GO:0051684) |
| 0.1 |
3.7 |
GO:0007176 |
regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
| 0.1 |
0.1 |
GO:2000353 |
positive regulation of endothelial cell apoptotic process(GO:2000353) |
| 0.1 |
2.1 |
GO:0071243 |
cellular response to arsenic-containing substance(GO:0071243) |
| 0.1 |
0.1 |
GO:0042536 |
negative regulation of tumor necrosis factor biosynthetic process(GO:0042536) |
| 0.1 |
0.3 |
GO:0034196 |
acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
| 0.1 |
0.4 |
GO:0035674 |
tricarboxylic acid transmembrane transport(GO:0035674) |
| 0.1 |
0.4 |
GO:0002378 |
immunoglobulin biosynthetic process(GO:0002378) |
| 0.1 |
0.8 |
GO:0035385 |
Roundabout signaling pathway(GO:0035385) |
| 0.1 |
0.3 |
GO:0043096 |
purine nucleobase salvage(GO:0043096) |
| 0.1 |
0.5 |
GO:0045869 |
negative regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045869) |
| 0.1 |
0.4 |
GO:0042160 |
plasma lipoprotein particle oxidation(GO:0034441) lipoprotein modification(GO:0042160) lipoprotein oxidation(GO:0042161) |
| 0.1 |
0.6 |
GO:0015812 |
gamma-aminobutyric acid transport(GO:0015812) |
| 0.1 |
0.1 |
GO:0036342 |
post-anal tail morphogenesis(GO:0036342) |
| 0.1 |
2.0 |
GO:0019388 |
galactose catabolic process(GO:0019388) |
| 0.1 |
3.4 |
GO:1904380 |
endoplasmic reticulum mannose trimming(GO:1904380) |
| 0.1 |
1.3 |
GO:0098734 |
macromolecule depalmitoylation(GO:0098734) |
| 0.1 |
0.4 |
GO:0001694 |
histamine biosynthetic process(GO:0001694) |
| 0.1 |
0.6 |
GO:0035063 |
nuclear speck organization(GO:0035063) |
| 0.1 |
1.6 |
GO:2000291 |
regulation of myoblast proliferation(GO:2000291) |
| 0.1 |
0.4 |
GO:0007343 |
egg activation(GO:0007343) |
| 0.1 |
0.3 |
GO:0038065 |
collagen-activated signaling pathway(GO:0038065) |
| 0.1 |
0.9 |
GO:0032515 |
negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
| 0.1 |
7.1 |
GO:0007157 |
heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
| 0.1 |
0.2 |
GO:0034316 |
negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
| 0.1 |
0.6 |
GO:0055014 |
atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
| 0.1 |
0.4 |
GO:0044771 |
meiotic cell cycle phase transition(GO:0044771) regulation of meiotic cell cycle phase transition(GO:1901993) negative regulation of meiotic cell cycle phase transition(GO:1901994) |
| 0.1 |
0.2 |
GO:0060743 |
epithelial cell maturation involved in prostate gland development(GO:0060743) |
| 0.1 |
1.7 |
GO:0090161 |
Golgi ribbon formation(GO:0090161) |
| 0.1 |
0.5 |
GO:0000103 |
sulfate assimilation(GO:0000103) |
| 0.1 |
0.9 |
GO:2001016 |
positive regulation of skeletal muscle cell differentiation(GO:2001016) |
| 0.1 |
1.2 |
GO:0018230 |
peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
| 0.1 |
0.4 |
GO:0061743 |
motor learning(GO:0061743) |
| 0.1 |
0.2 |
GO:0038166 |
angiotensin-activated signaling pathway(GO:0038166) |
| 0.1 |
0.9 |
GO:0035965 |
cardiolipin acyl-chain remodeling(GO:0035965) |
| 0.1 |
1.0 |
GO:0060547 |
negative regulation of necroptotic process(GO:0060546) negative regulation of necrotic cell death(GO:0060547) |
| 0.1 |
1.7 |
GO:1901550 |
regulation of endothelial cell development(GO:1901550) regulation of establishment of endothelial barrier(GO:1903140) |
| 0.1 |
7.7 |
GO:0006910 |
phagocytosis, recognition(GO:0006910) |
| 0.1 |
0.5 |
GO:0009750 |
response to fructose(GO:0009750) |
| 0.1 |
0.5 |
GO:0035999 |
tetrahydrofolate interconversion(GO:0035999) |
| 0.1 |
0.5 |
GO:0006102 |
isocitrate metabolic process(GO:0006102) |
| 0.1 |
0.5 |
GO:0035021 |
negative regulation of Rac protein signal transduction(GO:0035021) |
| 0.1 |
0.1 |
GO:2000179 |
positive regulation of neural precursor cell proliferation(GO:2000179) |
| 0.1 |
0.2 |
GO:0090344 |
negative regulation of cell aging(GO:0090344) |
| 0.1 |
0.2 |
GO:0060024 |
rhythmic synaptic transmission(GO:0060024) |
| 0.1 |
0.2 |
GO:0060700 |
regulation of ribonuclease activity(GO:0060700) |
| 0.1 |
1.0 |
GO:0044062 |
regulation of excretion(GO:0044062) |
| 0.1 |
0.1 |
GO:0007521 |
muscle cell fate determination(GO:0007521) |
| 0.1 |
0.8 |
GO:0006020 |
inositol metabolic process(GO:0006020) |
| 0.1 |
1.4 |
GO:0071498 |
cellular response to fluid shear stress(GO:0071498) |
| 0.1 |
0.5 |
GO:1901992 |
positive regulation of mitotic cell cycle phase transition(GO:1901992) |
| 0.1 |
0.7 |
GO:0043117 |
positive regulation of vascular permeability(GO:0043117) |
| 0.1 |
0.1 |
GO:0000466 |
maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000466) |
| 0.1 |
0.7 |
GO:0051934 |
dopamine uptake involved in synaptic transmission(GO:0051583) catecholamine uptake involved in synaptic transmission(GO:0051934) catecholamine uptake(GO:0090493) dopamine uptake(GO:0090494) |
| 0.1 |
0.9 |
GO:0006582 |
melanin metabolic process(GO:0006582) |
| 0.1 |
0.2 |
GO:0010193 |
response to ozone(GO:0010193) |
| 0.1 |
0.6 |
GO:0072526 |
pyridine-containing compound catabolic process(GO:0072526) |
| 0.1 |
0.2 |
GO:0048842 |
positive regulation of axon extension involved in axon guidance(GO:0048842) |
| 0.1 |
0.2 |
GO:0043932 |
ossification involved in bone remodeling(GO:0043932) |
| 0.1 |
1.3 |
GO:1900028 |
negative regulation of ruffle assembly(GO:1900028) |
| 0.1 |
0.3 |
GO:0032098 |
regulation of appetite(GO:0032098) |
| 0.1 |
2.2 |
GO:0035589 |
G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
| 0.1 |
0.1 |
GO:0006801 |
superoxide metabolic process(GO:0006801) |
| 0.1 |
1.5 |
GO:0070327 |
thyroid hormone transport(GO:0070327) |
| 0.1 |
0.1 |
GO:0036090 |
cleavage furrow ingression(GO:0036090) |
| 0.1 |
0.3 |
GO:0060081 |
membrane hyperpolarization(GO:0060081) |
| 0.1 |
0.6 |
GO:0060800 |
regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
| 0.1 |
0.3 |
GO:0042339 |
keratan sulfate metabolic process(GO:0042339) |
| 0.1 |
2.4 |
GO:0006465 |
signal peptide processing(GO:0006465) |
| 0.1 |
1.1 |
GO:0051561 |
positive regulation of mitochondrial calcium ion concentration(GO:0051561) |
| 0.1 |
1.0 |
GO:0051608 |
histamine transport(GO:0051608) |
| 0.1 |
0.3 |
GO:0006498 |
N-terminal protein lipidation(GO:0006498) |
| 0.1 |
0.1 |
GO:0051987 |
positive regulation of attachment of spindle microtubules to kinetochore(GO:0051987) |
| 0.1 |
1.9 |
GO:0097435 |
fibril organization(GO:0097435) |
| 0.1 |
0.7 |
GO:0018343 |
protein farnesylation(GO:0018343) |
| 0.1 |
0.1 |
GO:0060179 |
male mating behavior(GO:0060179) |
| 0.1 |
4.8 |
GO:0051310 |
metaphase plate congression(GO:0051310) |
| 0.1 |
0.3 |
GO:0045586 |
regulation of gamma-delta T cell differentiation(GO:0045586) |
| 0.1 |
0.3 |
GO:1901350 |
cell-cell signaling involved in cell-cell junction organization(GO:1901350) |
| 0.1 |
0.3 |
GO:0070682 |
proteasome regulatory particle assembly(GO:0070682) |
| 0.1 |
0.1 |
GO:0032079 |
positive regulation of endodeoxyribonuclease activity(GO:0032079) |
| 0.1 |
0.3 |
GO:0060670 |
branching involved in labyrinthine layer morphogenesis(GO:0060670) |
| 0.1 |
5.1 |
GO:0033119 |
negative regulation of RNA splicing(GO:0033119) |
| 0.1 |
0.5 |
GO:0043031 |
negative regulation of macrophage activation(GO:0043031) |
| 0.1 |
0.2 |
GO:0071484 |
cellular response to light intensity(GO:0071484) |
| 0.1 |
0.7 |
GO:0014850 |
response to muscle activity(GO:0014850) |
| 0.1 |
0.4 |
GO:1902255 |
positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
| 0.1 |
0.1 |
GO:0086100 |
endothelin receptor signaling pathway(GO:0086100) |
| 0.1 |
1.3 |
GO:0045187 |
regulation of circadian sleep/wake cycle, sleep(GO:0045187) |
| 0.1 |
0.3 |
GO:0071529 |
cementum mineralization(GO:0071529) |
| 0.1 |
1.2 |
GO:0098703 |
calcium ion import across plasma membrane(GO:0098703) calcium ion import into cell(GO:1990035) |
| 0.1 |
0.5 |
GO:0060979 |
vasculogenesis involved in coronary vascular morphogenesis(GO:0060979) |
| 0.1 |
2.3 |
GO:0000028 |
ribosomal small subunit assembly(GO:0000028) |
| 0.1 |
1.3 |
GO:0090557 |
establishment of endothelial intestinal barrier(GO:0090557) |
| 0.1 |
0.3 |
GO:2000687 |
negative regulation of rubidium ion transport(GO:2000681) negative regulation of rubidium ion transmembrane transporter activity(GO:2000687) |
| 0.1 |
1.5 |
GO:0018298 |
protein-chromophore linkage(GO:0018298) |
| 0.1 |
0.1 |
GO:0016256 |
N-glycan processing to lysosome(GO:0016256) |
| 0.1 |
0.4 |
GO:0071477 |
hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
| 0.1 |
0.3 |
GO:0060392 |
negative regulation of SMAD protein import into nucleus(GO:0060392) |
| 0.1 |
1.3 |
GO:0060088 |
auditory receptor cell stereocilium organization(GO:0060088) |
| 0.1 |
0.1 |
GO:0044116 |
growth involved in symbiotic interaction(GO:0044110) growth of symbiont involved in interaction with host(GO:0044116) growth of symbiont in host(GO:0044117) regulation of growth of symbiont in host(GO:0044126) modulation of growth of symbiont involved in interaction with host(GO:0044144) |
| 0.1 |
0.4 |
GO:0033123 |
positive regulation of cyclic nucleotide catabolic process(GO:0030807) positive regulation of cAMP catabolic process(GO:0030822) positive regulation of purine nucleotide catabolic process(GO:0033123) |
| 0.1 |
0.5 |
GO:1903204 |
regulation of oxidative stress-induced neuron death(GO:1903203) negative regulation of oxidative stress-induced neuron death(GO:1903204) |
| 0.1 |
0.9 |
GO:0006777 |
Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) |
| 0.1 |
0.3 |
GO:0075044 |
autophagy of host cells involved in interaction with symbiont(GO:0075044) autophagy involved in symbiotic interaction(GO:0075071) |
| 0.1 |
1.1 |
GO:0090218 |
positive regulation of lipid kinase activity(GO:0090218) |
| 0.1 |
0.6 |
GO:0007217 |
tachykinin receptor signaling pathway(GO:0007217) |
| 0.1 |
1.3 |
GO:0001542 |
ovulation from ovarian follicle(GO:0001542) |
| 0.1 |
0.3 |
GO:0006422 |
aspartyl-tRNA aminoacylation(GO:0006422) |
| 0.1 |
0.7 |
GO:0070345 |
negative regulation of fat cell proliferation(GO:0070345) |
| 0.1 |
1.5 |
GO:0016102 |
retinoic acid biosynthetic process(GO:0002138) diterpenoid biosynthetic process(GO:0016102) |
| 0.1 |
0.3 |
GO:0010897 |
negative regulation of triglyceride catabolic process(GO:0010897) |
| 0.1 |
0.9 |
GO:0048240 |
sperm capacitation(GO:0048240) |
| 0.1 |
0.8 |
GO:0060689 |
cell differentiation involved in salivary gland development(GO:0060689) |
| 0.1 |
0.6 |
GO:0070995 |
NADPH oxidation(GO:0070995) |
| 0.1 |
1.8 |
GO:0002323 |
natural killer cell activation involved in immune response(GO:0002323) |
| 0.1 |
0.1 |
GO:0060481 |
lobar bronchus epithelium development(GO:0060481) |
| 0.1 |
0.5 |
GO:0010644 |
cell communication by electrical coupling(GO:0010644) |
| 0.1 |
0.4 |
GO:0010286 |
heat acclimation(GO:0010286) cellular heat acclimation(GO:0070370) |
| 0.1 |
1.2 |
GO:0045162 |
clustering of voltage-gated sodium channels(GO:0045162) |
| 0.1 |
0.2 |
GO:0045964 |
positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
| 0.1 |
0.2 |
GO:0097296 |
activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097296) |
| 0.1 |
0.1 |
GO:0032696 |
negative regulation of interleukin-13 production(GO:0032696) |
| 0.1 |
0.1 |
GO:0030968 |
endoplasmic reticulum unfolded protein response(GO:0030968) |
| 0.1 |
0.2 |
GO:1902306 |
negative regulation of sodium ion transmembrane transport(GO:1902306) |
| 0.1 |
0.1 |
GO:0038163 |
thrombopoietin-mediated signaling pathway(GO:0038163) |
| 0.1 |
2.7 |
GO:0030252 |
growth hormone secretion(GO:0030252) |
| 0.1 |
0.5 |
GO:1902714 |
negative regulation of interferon-gamma secretion(GO:1902714) |
| 0.1 |
1.1 |
GO:0071470 |
cellular response to osmotic stress(GO:0071470) |
| 0.1 |
0.5 |
GO:0032218 |
riboflavin transport(GO:0032218) |
| 0.1 |
0.5 |
GO:1900825 |
regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
| 0.1 |
0.5 |
GO:0010836 |
negative regulation of protein ADP-ribosylation(GO:0010836) |
| 0.1 |
0.3 |
GO:0090362 |
positive regulation of platelet-derived growth factor production(GO:0090362) |
| 0.1 |
0.4 |
GO:0006975 |
DNA damage induced protein phosphorylation(GO:0006975) |
| 0.1 |
0.3 |
GO:0036480 |
neuron intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0036480) regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903376) negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
| 0.1 |
0.3 |
GO:0003383 |
apical constriction(GO:0003383) |
| 0.1 |
0.6 |
GO:0071763 |
nuclear membrane organization(GO:0071763) |
| 0.1 |
0.4 |
GO:0021891 |
olfactory bulb interneuron development(GO:0021891) |
| 0.1 |
0.2 |
GO:0006425 |
glutaminyl-tRNA aminoacylation(GO:0006425) |
| 0.1 |
1.6 |
GO:0007076 |
mitotic chromosome condensation(GO:0007076) |
| 0.1 |
0.6 |
GO:0048854 |
brain morphogenesis(GO:0048854) |
| 0.1 |
5.5 |
GO:0015909 |
long-chain fatty acid transport(GO:0015909) |
| 0.1 |
0.3 |
GO:0046628 |
positive regulation of insulin receptor signaling pathway(GO:0046628) |
| 0.1 |
2.6 |
GO:0042744 |
hydrogen peroxide catabolic process(GO:0042744) |
| 0.1 |
0.3 |
GO:0035552 |
oxidative single-stranded DNA demethylation(GO:0035552) |
| 0.1 |
0.4 |
GO:0097045 |
activation of blood coagulation via clotting cascade(GO:0002543) phosphatidylserine exposure on blood platelet(GO:0097045) positive regulation of potassium ion export(GO:1902304) |
| 0.1 |
0.1 |
GO:0055001 |
muscle cell development(GO:0055001) |
| 0.1 |
0.3 |
GO:0008212 |
mineralocorticoid biosynthetic process(GO:0006705) mineralocorticoid metabolic process(GO:0008212) |
| 0.1 |
1.7 |
GO:0071294 |
cellular response to zinc ion(GO:0071294) |
| 0.1 |
0.4 |
GO:0090527 |
actin filament reorganization(GO:0090527) |
| 0.1 |
0.1 |
GO:1903756 |
regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903756) negative regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903758) |
| 0.1 |
0.5 |
GO:0018364 |
peptidyl-glutamine methylation(GO:0018364) |
| 0.1 |
0.6 |
GO:0048286 |
lung alveolus development(GO:0048286) |
| 0.1 |
0.7 |
GO:2001013 |
epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
| 0.1 |
1.0 |
GO:0031119 |
tRNA pseudouridine synthesis(GO:0031119) |
| 0.1 |
0.1 |
GO:0071895 |
odontoblast differentiation(GO:0071895) |
| 0.1 |
0.4 |
GO:0051127 |
positive regulation of actin nucleation(GO:0051127) |
| 0.1 |
0.5 |
GO:0030047 |
actin modification(GO:0030047) |
| 0.1 |
0.1 |
GO:0060268 |
negative regulation of respiratory burst(GO:0060268) |
| 0.1 |
0.3 |
GO:0030505 |
inorganic diphosphate transport(GO:0030505) |
| 0.1 |
1.3 |
GO:0035090 |
maintenance of apical/basal cell polarity(GO:0035090) maintenance of epithelial cell apical/basal polarity(GO:0045199) |
| 0.1 |
1.3 |
GO:0032292 |
myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
| 0.1 |
0.9 |
GO:0090646 |
mitochondrial tRNA processing(GO:0090646) |
| 0.1 |
0.6 |
GO:0034378 |
chylomicron assembly(GO:0034378) |
| 0.1 |
0.4 |
GO:0048739 |
cardiac muscle fiber development(GO:0048739) |
| 0.1 |
0.8 |
GO:0046078 |
dUMP metabolic process(GO:0046078) |
| 0.1 |
0.3 |
GO:0002429 |
immune response-activating cell surface receptor signaling pathway(GO:0002429) |
| 0.1 |
0.4 |
GO:2000852 |
corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
| 0.1 |
1.5 |
GO:0003416 |
endochondral bone growth(GO:0003416) |
| 0.1 |
1.1 |
GO:0060575 |
intestinal epithelial cell differentiation(GO:0060575) |
| 0.1 |
0.6 |
GO:0038172 |
interleukin-33-mediated signaling pathway(GO:0038172) |
| 0.1 |
1.0 |
GO:0015939 |
pantothenate metabolic process(GO:0015939) |
| 0.1 |
0.3 |
GO:0055059 |
asymmetric neuroblast division(GO:0055059) |
| 0.1 |
0.4 |
GO:0043128 |
regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043126) positive regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043128) |
| 0.1 |
0.4 |
GO:0046125 |
thymidine metabolic process(GO:0046104) pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
| 0.1 |
0.7 |
GO:0009972 |
cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
| 0.1 |
0.8 |
GO:0002281 |
macrophage activation involved in immune response(GO:0002281) |
| 0.1 |
0.9 |
GO:0051014 |
actin filament severing(GO:0051014) |
| 0.1 |
0.3 |
GO:1902630 |
regulation of membrane hyperpolarization(GO:1902630) |
| 0.1 |
0.5 |
GO:0010756 |
positive regulation of plasminogen activation(GO:0010756) |
| 0.1 |
0.3 |
GO:0048213 |
Golgi vesicle prefusion complex stabilization(GO:0048213) |
| 0.1 |
0.1 |
GO:1902897 |
regulation of postsynaptic density protein 95 clustering(GO:1902897) |
| 0.1 |
0.7 |
GO:2000311 |
regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
| 0.1 |
0.2 |
GO:0039534 |
negative regulation of MDA-5 signaling pathway(GO:0039534) |
| 0.1 |
0.5 |
GO:0009113 |
purine nucleobase biosynthetic process(GO:0009113) |
| 0.1 |
0.7 |
GO:0048712 |
negative regulation of astrocyte differentiation(GO:0048712) |
| 0.1 |
0.3 |
GO:0060380 |
regulation of single-stranded telomeric DNA binding(GO:0060380) positive regulation of single-stranded telomeric DNA binding(GO:0060381) regulation of telomeric DNA binding(GO:1904742) positive regulation of telomeric DNA binding(GO:1904744) |
| 0.1 |
1.8 |
GO:0070208 |
protein heterotrimerization(GO:0070208) |
| 0.1 |
0.9 |
GO:0070933 |
histone H4 deacetylation(GO:0070933) |
| 0.1 |
0.1 |
GO:0031057 |
negative regulation of histone modification(GO:0031057) |
| 0.1 |
0.4 |
GO:0031536 |
positive regulation of exit from mitosis(GO:0031536) |
| 0.1 |
0.1 |
GO:0036515 |
serotonergic neuron axon guidance(GO:0036515) |
| 0.1 |
0.3 |
GO:0090675 |
intermicrovillar adhesion(GO:0090675) |
| 0.1 |
0.2 |
GO:0000472 |
endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000472) rRNA 5'-end processing(GO:0000967) ncRNA 5'-end processing(GO:0034471) |
| 0.1 |
0.6 |
GO:0097411 |
hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
| 0.1 |
0.2 |
GO:0043385 |
mycotoxin metabolic process(GO:0043385) aflatoxin metabolic process(GO:0046222) organic heteropentacyclic compound metabolic process(GO:1901376) |
| 0.1 |
0.2 |
GO:0090071 |
negative regulation of ribosome biogenesis(GO:0090071) |
| 0.1 |
0.2 |
GO:1990523 |
bone regeneration(GO:1990523) |
| 0.1 |
0.5 |
GO:0061042 |
vascular wound healing(GO:0061042) |
| 0.1 |
0.7 |
GO:0060026 |
convergent extension(GO:0060026) |
| 0.1 |
1.2 |
GO:0035092 |
sperm chromatin condensation(GO:0035092) |
| 0.1 |
0.8 |
GO:0035871 |
protein K11-linked deubiquitination(GO:0035871) |
| 0.1 |
0.9 |
GO:0001976 |
neurological system process involved in regulation of systemic arterial blood pressure(GO:0001976) |
| 0.1 |
0.4 |
GO:0007525 |
somatic muscle development(GO:0007525) |
| 0.1 |
0.3 |
GO:0042532 |
negative regulation of tyrosine phosphorylation of STAT protein(GO:0042532) |
| 0.1 |
3.0 |
GO:0043001 |
Golgi to plasma membrane protein transport(GO:0043001) |
| 0.1 |
3.2 |
GO:1903861 |
regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
| 0.1 |
1.7 |
GO:0006206 |
pyrimidine nucleobase metabolic process(GO:0006206) |
| 0.1 |
0.6 |
GO:0010288 |
response to lead ion(GO:0010288) |
| 0.1 |
0.6 |
GO:0036293 |
response to decreased oxygen levels(GO:0036293) |
| 0.1 |
0.5 |
GO:0014877 |
response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
| 0.1 |
0.2 |
GO:0033044 |
regulation of chromosome organization(GO:0033044) |
| 0.1 |
1.7 |
GO:0090286 |
cytoskeletal anchoring at nuclear membrane(GO:0090286) |
| 0.1 |
0.3 |
GO:1902490 |
regulation of sperm capacitation(GO:1902490) |
| 0.1 |
0.7 |
GO:0010968 |
regulation of microtubule nucleation(GO:0010968) |
| 0.1 |
1.1 |
GO:0007597 |
blood coagulation, intrinsic pathway(GO:0007597) |
| 0.1 |
0.2 |
GO:0019482 |
beta-alanine metabolic process(GO:0019482) |
| 0.1 |
0.6 |
GO:0097178 |
ruffle assembly(GO:0097178) |
| 0.1 |
1.3 |
GO:0006995 |
cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 0.1 |
0.1 |
GO:0051646 |
mitochondrion localization(GO:0051646) |
| 0.1 |
0.7 |
GO:0035878 |
nail development(GO:0035878) |
| 0.1 |
0.5 |
GO:0060712 |
spongiotrophoblast layer development(GO:0060712) |
| 0.1 |
0.7 |
GO:0033689 |
negative regulation of osteoblast proliferation(GO:0033689) |
| 0.1 |
0.2 |
GO:0030262 |
cellular component disassembly involved in execution phase of apoptosis(GO:0006921) apoptotic nuclear changes(GO:0030262) |
| 0.1 |
0.3 |
GO:0016185 |
synaptic vesicle budding from presynaptic endocytic zone membrane(GO:0016185) |
| 0.1 |
1.0 |
GO:0001833 |
inner cell mass cell proliferation(GO:0001833) |
| 0.1 |
0.3 |
GO:0061739 |
protein lipidation involved in autophagosome assembly(GO:0061739) |
| 0.1 |
0.3 |
GO:0036337 |
Fas signaling pathway(GO:0036337) |
| 0.1 |
0.4 |
GO:0010832 |
negative regulation of myotube differentiation(GO:0010832) |
| 0.1 |
0.2 |
GO:0009583 |
detection of light stimulus(GO:0009583) |
| 0.1 |
0.3 |
GO:0072656 |
maintenance of protein location in mitochondrion(GO:0072656) |
| 0.1 |
0.3 |
GO:0010816 |
substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
| 0.1 |
3.4 |
GO:0030206 |
chondroitin sulfate biosynthetic process(GO:0030206) |
| 0.1 |
0.3 |
GO:0050650 |
chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
| 0.1 |
0.3 |
GO:0018201 |
peptidyl-glycine modification(GO:0018201) |
| 0.1 |
0.2 |
GO:0042989 |
sequestering of actin monomers(GO:0042989) |
| 0.1 |
0.3 |
GO:0018126 |
protein hydroxylation(GO:0018126) peptidyl-proline hydroxylation(GO:0019511) |
| 0.1 |
0.4 |
GO:0032808 |
lacrimal gland development(GO:0032808) |
| 0.1 |
0.1 |
GO:0009629 |
response to gravity(GO:0009629) |
| 0.1 |
0.7 |
GO:0046940 |
nucleoside monophosphate phosphorylation(GO:0046940) |
| 0.1 |
0.2 |
GO:0019674 |
NAD metabolic process(GO:0019674) |
| 0.1 |
1.5 |
GO:0042347 |
negative regulation of NF-kappaB import into nucleus(GO:0042347) |
| 0.1 |
0.9 |
GO:0000733 |
DNA strand renaturation(GO:0000733) |
| 0.1 |
0.9 |
GO:0010919 |
regulation of inositol phosphate biosynthetic process(GO:0010919) |
| 0.1 |
0.3 |
GO:0006613 |
cotranslational protein targeting to membrane(GO:0006613) |
| 0.1 |
1.0 |
GO:0051775 |
response to redox state(GO:0051775) |
| 0.1 |
0.1 |
GO:1905064 |
negative regulation of vascular smooth muscle cell differentiation(GO:1905064) |
| 0.1 |
1.0 |
GO:0045742 |
positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) |
| 0.1 |
0.5 |
GO:0035865 |
cellular response to potassium ion(GO:0035865) |
| 0.1 |
0.2 |
GO:0006532 |
aspartate biosynthetic process(GO:0006532) aspartate catabolic process(GO:0006533) |
| 0.1 |
0.4 |
GO:1903416 |
response to glycoside(GO:1903416) |
| 0.1 |
0.6 |
GO:0015840 |
urea transport(GO:0015840) |
| 0.1 |
0.1 |
GO:0032455 |
nerve growth factor processing(GO:0032455) |
| 0.1 |
0.7 |
GO:0040016 |
embryonic cleavage(GO:0040016) |
| 0.1 |
0.4 |
GO:0070309 |
lens fiber cell morphogenesis(GO:0070309) |
| 0.1 |
0.7 |
GO:0001731 |
formation of translation preinitiation complex(GO:0001731) |
| 0.1 |
0.2 |
GO:0043418 |
homocysteine catabolic process(GO:0043418) |
| 0.1 |
0.8 |
GO:0039536 |
negative regulation of RIG-I signaling pathway(GO:0039536) |
| 0.1 |
0.6 |
GO:0070212 |
protein poly-ADP-ribosylation(GO:0070212) |
| 0.1 |
0.2 |
GO:0031125 |
rRNA 3'-end processing(GO:0031125) |
| 0.1 |
0.7 |
GO:0031639 |
plasminogen activation(GO:0031639) |
| 0.1 |
0.2 |
GO:0007492 |
endoderm development(GO:0007492) |
| 0.1 |
1.2 |
GO:0007084 |
mitotic nuclear envelope reassembly(GO:0007084) |
| 0.1 |
0.7 |
GO:0045954 |
positive regulation of natural killer cell mediated cytotoxicity(GO:0045954) |
| 0.1 |
0.2 |
GO:0001927 |
exocyst assembly(GO:0001927) |
| 0.1 |
0.9 |
GO:0036010 |
protein localization to endosome(GO:0036010) |
| 0.1 |
0.1 |
GO:0010040 |
response to iron(II) ion(GO:0010040) |
| 0.1 |
0.6 |
GO:0021615 |
glossopharyngeal nerve development(GO:0021563) glossopharyngeal nerve morphogenesis(GO:0021615) |
| 0.1 |
0.6 |
GO:0002090 |
regulation of receptor internalization(GO:0002090) |
| 0.1 |
0.3 |
GO:0061107 |
seminal vesicle development(GO:0061107) |
| 0.1 |
1.8 |
GO:0045116 |
protein neddylation(GO:0045116) |
| 0.1 |
0.6 |
GO:0070973 |
protein localization to endoplasmic reticulum exit site(GO:0070973) |
| 0.1 |
0.5 |
GO:0046629 |
gamma-delta T cell activation(GO:0046629) |
| 0.1 |
1.9 |
GO:0003254 |
regulation of membrane depolarization(GO:0003254) |
| 0.1 |
0.6 |
GO:0060770 |
negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
| 0.1 |
2.9 |
GO:0043928 |
exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
| 0.1 |
0.5 |
GO:0043696 |
dedifferentiation(GO:0043696) cell dedifferentiation(GO:0043697) |
| 0.1 |
0.2 |
GO:0033140 |
negative regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033140) |
| 0.1 |
0.2 |
GO:0035281 |
pre-miRNA export from nucleus(GO:0035281) |
| 0.1 |
0.1 |
GO:0050435 |
beta-amyloid metabolic process(GO:0050435) |
| 0.1 |
0.2 |
GO:0051754 |
meiotic sister chromatid cohesion, centromeric(GO:0051754) |
| 0.1 |
0.8 |
GO:0045717 |
negative regulation of fatty acid biosynthetic process(GO:0045717) |
| 0.1 |
0.6 |
GO:0045104 |
intermediate filament cytoskeleton organization(GO:0045104) |
| 0.1 |
0.8 |
GO:0001556 |
oocyte maturation(GO:0001556) |
| 0.1 |
3.2 |
GO:1904893 |
negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
| 0.1 |
0.5 |
GO:0006516 |
glycoprotein catabolic process(GO:0006516) |
| 0.1 |
0.2 |
GO:0060708 |
spongiotrophoblast differentiation(GO:0060708) |
| 0.1 |
0.1 |
GO:0042636 |
negative regulation of hair cycle(GO:0042636) |
| 0.1 |
0.2 |
GO:0071941 |
nitrogen cycle metabolic process(GO:0071941) |
| 0.1 |
0.4 |
GO:0043278 |
response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
| 0.1 |
0.5 |
GO:0031017 |
exocrine pancreas development(GO:0031017) |
| 0.1 |
0.2 |
GO:1902019 |
regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
| 0.1 |
0.5 |
GO:0050957 |
equilibrioception(GO:0050957) |
| 0.1 |
0.9 |
GO:0051764 |
actin crosslink formation(GO:0051764) |
| 0.1 |
0.2 |
GO:0046952 |
ketone body catabolic process(GO:0046952) |
| 0.1 |
1.4 |
GO:0090110 |
cargo loading into COPII-coated vesicle(GO:0090110) |
| 0.1 |
0.3 |
GO:1902626 |
assembly of large subunit precursor of preribosome(GO:1902626) |
| 0.1 |
0.6 |
GO:0031000 |
response to caffeine(GO:0031000) |
| 0.1 |
0.1 |
GO:1901032 |
cell death in response to hydrogen peroxide(GO:0036474) negative regulation of response to reactive oxygen species(GO:1901032) regulation of hydrogen peroxide-induced cell death(GO:1903205) negative regulation of hydrogen peroxide-induced cell death(GO:1903206) |
| 0.1 |
1.6 |
GO:0035728 |
response to hepatocyte growth factor(GO:0035728) |
| 0.1 |
0.7 |
GO:1900112 |
regulation of histone H3-K9 trimethylation(GO:1900112) |
| 0.1 |
0.6 |
GO:0006600 |
creatine metabolic process(GO:0006600) |
| 0.1 |
0.2 |
GO:2000171 |
negative regulation of dendrite development(GO:2000171) |
| 0.1 |
0.6 |
GO:0051988 |
regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
| 0.1 |
0.7 |
GO:0097396 |
response to interleukin-17(GO:0097396) cellular response to interleukin-17(GO:0097398) |
| 0.1 |
0.5 |
GO:0035411 |
catenin import into nucleus(GO:0035411) |
| 0.1 |
0.4 |
GO:0051573 |
negative regulation of histone H3-K9 methylation(GO:0051573) |
| 0.1 |
0.6 |
GO:0006662 |
glycerol ether metabolic process(GO:0006662) |
| 0.1 |
0.2 |
GO:0043277 |
apoptotic cell clearance(GO:0043277) |
| 0.1 |
0.3 |
GO:2001020 |
regulation of response to DNA damage stimulus(GO:2001020) |
| 0.1 |
1.7 |
GO:0005980 |
glycogen catabolic process(GO:0005980) |
| 0.1 |
1.9 |
GO:0022400 |
regulation of rhodopsin mediated signaling pathway(GO:0022400) |
| 0.1 |
1.2 |
GO:0070306 |
lens fiber cell differentiation(GO:0070306) |
| 0.1 |
9.4 |
GO:0006614 |
SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
| 0.1 |
0.3 |
GO:0043616 |
keratinocyte proliferation(GO:0043616) |
| 0.1 |
0.3 |
GO:0045617 |
negative regulation of keratinocyte differentiation(GO:0045617) |
| 0.1 |
0.3 |
GO:0001865 |
NK T cell differentiation(GO:0001865) |
| 0.1 |
0.3 |
GO:0071955 |
recycling endosome to Golgi transport(GO:0071955) |
| 0.1 |
0.1 |
GO:0035494 |
SNARE complex disassembly(GO:0035494) |
| 0.1 |
0.2 |
GO:0006433 |
prolyl-tRNA aminoacylation(GO:0006433) |
| 0.1 |
0.1 |
GO:0018027 |
peptidyl-lysine dimethylation(GO:0018027) |
| 0.1 |
0.1 |
GO:0043029 |
T cell homeostasis(GO:0043029) |
| 0.1 |
0.2 |
GO:0015772 |
disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
| 0.1 |
0.2 |
GO:0060613 |
fat pad development(GO:0060613) |
| 0.1 |
0.3 |
GO:0003197 |
endocardial cushion development(GO:0003197) |
| 0.1 |
0.5 |
GO:0016191 |
synaptic vesicle uncoating(GO:0016191) vesicle uncoating(GO:0072319) |
| 0.1 |
0.7 |
GO:0034356 |
NAD biosynthesis via nicotinamide riboside salvage pathway(GO:0034356) |
| 0.1 |
0.3 |
GO:0097498 |
endothelial tube lumen extension(GO:0097498) |
| 0.1 |
0.3 |
GO:0002643 |
regulation of tolerance induction(GO:0002643) |
| 0.1 |
0.3 |
GO:0006546 |
glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
| 0.1 |
0.6 |
GO:0061088 |
regulation of sequestering of zinc ion(GO:0061088) |
| 0.1 |
1.9 |
GO:0000281 |
mitotic cytokinesis(GO:0000281) |
| 0.1 |
0.5 |
GO:0006682 |
galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
| 0.1 |
0.4 |
GO:0032185 |
septin cytoskeleton organization(GO:0032185) |
| 0.1 |
0.4 |
GO:0010889 |
regulation of sequestering of triglyceride(GO:0010889) sequestering of triglyceride(GO:0030730) |
| 0.1 |
0.3 |
GO:2000660 |
negative regulation of interleukin-1-mediated signaling pathway(GO:2000660) |
| 0.1 |
0.1 |
GO:1904352 |
positive regulation of protein catabolic process in the vacuole(GO:1904352) |
| 0.1 |
0.1 |
GO:0007016 |
cytoskeletal anchoring at plasma membrane(GO:0007016) |
| 0.1 |
0.2 |
GO:0030070 |
insulin processing(GO:0030070) |
| 0.1 |
0.3 |
GO:0007626 |
locomotory behavior(GO:0007626) |
| 0.1 |
0.2 |
GO:0035897 |
proteolysis in other organism(GO:0035897) |
| 0.1 |
0.9 |
GO:0006044 |
N-acetylglucosamine metabolic process(GO:0006044) |
| 0.1 |
0.3 |
GO:0030220 |
platelet formation(GO:0030220) |
| 0.1 |
1.0 |
GO:0090140 |
regulation of mitochondrial fission(GO:0090140) |
| 0.1 |
0.4 |
GO:0007023 |
post-chaperonin tubulin folding pathway(GO:0007023) |
| 0.1 |
0.1 |
GO:1904751 |
positive regulation of protein localization to nucleolus(GO:1904751) |
| 0.1 |
0.1 |
GO:1903588 |
negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903588) |
| 0.1 |
0.5 |
GO:0006265 |
DNA topological change(GO:0006265) |
| 0.1 |
0.5 |
GO:0045022 |
early endosome to late endosome transport(GO:0045022) |
| 0.1 |
0.3 |
GO:0006049 |
UDP-N-acetylglucosamine catabolic process(GO:0006049) |
| 0.1 |
0.1 |
GO:0060662 |
tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
| 0.1 |
1.7 |
GO:0006939 |
smooth muscle contraction(GO:0006939) |
| 0.1 |
0.5 |
GO:0070779 |
D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
| 0.1 |
0.1 |
GO:0070162 |
adiponectin secretion(GO:0070162) regulation of adiponectin secretion(GO:0070163) negative regulation of adiponectin secretion(GO:0070164) |
| 0.1 |
0.1 |
GO:2001140 |
regulation of phospholipid transport(GO:2001138) positive regulation of phospholipid transport(GO:2001140) |
| 0.1 |
0.2 |
GO:0060073 |
micturition(GO:0060073) |
| 0.1 |
0.2 |
GO:1900738 |
regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
| 0.1 |
0.3 |
GO:2000394 |
positive regulation of lamellipodium morphogenesis(GO:2000394) |
| 0.1 |
0.4 |
GO:0061469 |
regulation of type B pancreatic cell proliferation(GO:0061469) |
| 0.1 |
0.5 |
GO:1903599 |
positive regulation of mitophagy(GO:1903599) |
| 0.1 |
0.3 |
GO:0030261 |
chromosome condensation(GO:0030261) |
| 0.1 |
0.5 |
GO:0000160 |
phosphorelay signal transduction system(GO:0000160) |
| 0.1 |
0.9 |
GO:0045651 |
positive regulation of macrophage differentiation(GO:0045651) |
| 0.1 |
0.5 |
GO:0019236 |
response to pheromone(GO:0019236) |
| 0.1 |
0.2 |
GO:2001300 |
lipoxin metabolic process(GO:2001300) |
| 0.1 |
2.0 |
GO:0045070 |
positive regulation of viral genome replication(GO:0045070) |
| 0.1 |
0.2 |
GO:1903799 |
negative regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903799) |
| 0.1 |
0.6 |
GO:1903146 |
regulation of mitophagy(GO:1903146) |
| 0.1 |
0.1 |
GO:0032525 |
somite rostral/caudal axis specification(GO:0032525) |
| 0.1 |
0.3 |
GO:0048265 |
response to pain(GO:0048265) |
| 0.1 |
3.6 |
GO:0030574 |
collagen catabolic process(GO:0030574) |
| 0.1 |
0.4 |
GO:0032688 |
negative regulation of interferon-beta production(GO:0032688) |
| 0.1 |
0.1 |
GO:0036500 |
ATF6-mediated unfolded protein response(GO:0036500) |
| 0.1 |
0.1 |
GO:0060935 |
cardiac fibroblast cell differentiation(GO:0060935) cardiac fibroblast cell development(GO:0060936) epicardium-derived cardiac fibroblast cell differentiation(GO:0060938) epicardium-derived cardiac fibroblast cell development(GO:0060939) epithelial to mesenchymal transition involved in cardiac fibroblast development(GO:0060940) |
| 0.1 |
0.4 |
GO:0045654 |
positive regulation of megakaryocyte differentiation(GO:0045654) |
| 0.1 |
0.1 |
GO:0060823 |
canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060823) |
| 0.1 |
0.1 |
GO:0032494 |
response to peptidoglycan(GO:0032494) |
| 0.1 |
0.1 |
GO:0030316 |
osteoclast differentiation(GO:0030316) |
| 0.1 |
0.9 |
GO:0032060 |
bleb assembly(GO:0032060) |
| 0.1 |
0.3 |
GO:1904706 |
negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
| 0.1 |
0.6 |
GO:0071526 |
semaphorin-plexin signaling pathway(GO:0071526) |
| 0.1 |
1.1 |
GO:0002062 |
chondrocyte differentiation(GO:0002062) |
| 0.1 |
0.5 |
GO:0048280 |
vesicle fusion with Golgi apparatus(GO:0048280) |
| 0.1 |
0.3 |
GO:0000738 |
DNA catabolic process, exonucleolytic(GO:0000738) |
| 0.1 |
0.4 |
GO:0016557 |
peroxisome membrane biogenesis(GO:0016557) |
| 0.1 |
0.2 |
GO:0060316 |
positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
| 0.1 |
0.7 |
GO:0032790 |
ribosome disassembly(GO:0032790) |
| 0.1 |
0.4 |
GO:0046498 |
S-adenosylhomocysteine metabolic process(GO:0046498) |
| 0.1 |
0.2 |
GO:0051897 |
positive regulation of protein kinase B signaling(GO:0051897) |
| 0.1 |
0.2 |
GO:0000414 |
regulation of histone H3-K36 methylation(GO:0000414) |
| 0.1 |
0.5 |
GO:0048742 |
regulation of skeletal muscle fiber development(GO:0048742) |
| 0.1 |
1.8 |
GO:1903959 |
regulation of anion transmembrane transport(GO:1903959) |
| 0.1 |
1.3 |
GO:0090200 |
positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
| 0.1 |
0.1 |
GO:2001234 |
negative regulation of apoptotic signaling pathway(GO:2001234) |
| 0.1 |
0.1 |
GO:0071921 |
establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
| 0.1 |
0.2 |
GO:0007431 |
salivary gland development(GO:0007431) |
| 0.1 |
0.1 |
GO:0080182 |
histone H3-K4 trimethylation(GO:0080182) |
| 0.1 |
0.1 |
GO:0071361 |
cellular response to ethanol(GO:0071361) |
| 0.1 |
0.6 |
GO:0097369 |
sodium ion import(GO:0097369) sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
| 0.1 |
0.1 |
GO:0034312 |
diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
| 0.1 |
0.3 |
GO:0030579 |
ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
| 0.1 |
0.2 |
GO:1903215 |
negative regulation of protein targeting to mitochondrion(GO:1903215) |
| 0.1 |
0.4 |
GO:0070940 |
dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 0.1 |
0.1 |
GO:0060696 |
regulation of phospholipid catabolic process(GO:0060696) |
| 0.1 |
0.1 |
GO:1904292 |
regulation of ERAD pathway(GO:1904292) |
| 0.1 |
0.6 |
GO:0030388 |
fructose 1,6-bisphosphate metabolic process(GO:0030388) |
| 0.1 |
0.5 |
GO:1901387 |
positive regulation of voltage-gated calcium channel activity(GO:1901387) |
| 0.1 |
0.2 |
GO:0046626 |
regulation of insulin receptor signaling pathway(GO:0046626) |
| 0.1 |
0.2 |
GO:0006001 |
fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) |
| 0.1 |
0.2 |
GO:0015684 |
ferrous iron transport(GO:0015684) ferrous iron transmembrane transport(GO:1903874) |
| 0.1 |
0.7 |
GO:0007021 |
tubulin complex assembly(GO:0007021) |
| 0.1 |
0.1 |
GO:0015919 |
peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
| 0.1 |
0.2 |
GO:0051152 |
positive regulation of smooth muscle cell differentiation(GO:0051152) |
| 0.1 |
1.2 |
GO:0050919 |
negative chemotaxis(GO:0050919) |
| 0.1 |
0.5 |
GO:1900181 |
negative regulation of protein localization to nucleus(GO:1900181) |
| 0.1 |
0.2 |
GO:0035549 |
positive regulation of interferon-beta secretion(GO:0035549) |
| 0.1 |
0.2 |
GO:0051533 |
positive regulation of NFAT protein import into nucleus(GO:0051533) |
| 0.1 |
0.5 |
GO:0000463 |
maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
| 0.1 |
0.7 |
GO:0060716 |
labyrinthine layer blood vessel development(GO:0060716) |
| 0.1 |
0.8 |
GO:0002430 |
complement receptor mediated signaling pathway(GO:0002430) |
| 0.1 |
0.2 |
GO:0048227 |
plasma membrane to endosome transport(GO:0048227) |
| 0.1 |
2.1 |
GO:2001244 |
positive regulation of intrinsic apoptotic signaling pathway(GO:2001244) |
| 0.1 |
0.2 |
GO:0097120 |
receptor localization to synapse(GO:0097120) |
| 0.1 |
1.9 |
GO:0007189 |
adenylate cyclase-activating G-protein coupled receptor signaling pathway(GO:0007189) |
| 0.1 |
0.2 |
GO:0033512 |
L-lysine catabolic process to acetyl-CoA via saccharopine(GO:0033512) |
| 0.1 |
1.1 |
GO:0050860 |
negative regulation of T cell receptor signaling pathway(GO:0050860) |
| 0.1 |
0.2 |
GO:2000483 |
negative regulation of interleukin-8 secretion(GO:2000483) |
| 0.1 |
0.2 |
GO:0046166 |
glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
| 0.1 |
1.1 |
GO:0061003 |
positive regulation of dendritic spine morphogenesis(GO:0061003) |
| 0.1 |
0.1 |
GO:0022417 |
protein maturation by protein folding(GO:0022417) |
| 0.1 |
0.1 |
GO:0031284 |
positive regulation of guanylate cyclase activity(GO:0031284) |
| 0.1 |
0.2 |
GO:0045667 |
regulation of osteoblast differentiation(GO:0045667) |
| 0.1 |
0.2 |
GO:0072376 |
complement activation(GO:0006956) protein activation cascade(GO:0072376) |
| 0.1 |
0.1 |
GO:0048194 |
Golgi vesicle budding(GO:0048194) |
| 0.1 |
0.1 |
GO:0007270 |
neuron-neuron synaptic transmission(GO:0007270) |
| 0.1 |
0.1 |
GO:1903939 |
regulation of TORC2 signaling(GO:1903939) |
| 0.1 |
3.4 |
GO:0042147 |
retrograde transport, endosome to Golgi(GO:0042147) |
| 0.1 |
2.9 |
GO:0018279 |
peptidyl-asparagine modification(GO:0018196) protein N-linked glycosylation via asparagine(GO:0018279) |
| 0.1 |
0.6 |
GO:0001964 |
startle response(GO:0001964) |
| 0.1 |
2.1 |
GO:0038083 |
peptidyl-tyrosine autophosphorylation(GO:0038083) |
| 0.1 |
0.3 |
GO:0007135 |
meiosis II(GO:0007135) |
| 0.1 |
0.1 |
GO:0045056 |
transcytosis(GO:0045056) |
| 0.1 |
0.1 |
GO:0045647 |
negative regulation of erythrocyte differentiation(GO:0045647) |
| 0.1 |
0.2 |
GO:0010643 |
cell communication by chemical coupling(GO:0010643) |
| 0.1 |
0.2 |
GO:0051086 |
chaperone mediated protein folding independent of cofactor(GO:0051086) |
| 0.1 |
0.3 |
GO:0014809 |
regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014809) |
| 0.1 |
0.7 |
GO:0033233 |
regulation of protein sumoylation(GO:0033233) |
| 0.1 |
1.2 |
GO:0030212 |
hyaluronan metabolic process(GO:0030212) |
| 0.1 |
3.3 |
GO:0006890 |
retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
| 0.1 |
0.2 |
GO:0071670 |
smooth muscle cell chemotaxis(GO:0071670) |
| 0.1 |
0.3 |
GO:0060638 |
mesenchymal-epithelial cell signaling(GO:0060638) |
| 0.1 |
0.4 |
GO:0035909 |
aorta morphogenesis(GO:0035909) |
| 0.1 |
0.4 |
GO:0007512 |
adult heart development(GO:0007512) |
| 0.1 |
1.3 |
GO:0045747 |
positive regulation of Notch signaling pathway(GO:0045747) |
| 0.1 |
0.2 |
GO:0070172 |
positive regulation of tooth mineralization(GO:0070172) |
| 0.1 |
1.1 |
GO:2001238 |
positive regulation of extrinsic apoptotic signaling pathway(GO:2001238) |
| 0.1 |
0.6 |
GO:0014887 |
muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
| 0.1 |
1.4 |
GO:0016338 |
calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 0.1 |
0.4 |
GO:0051725 |
protein de-ADP-ribosylation(GO:0051725) |
| 0.1 |
0.4 |
GO:2000344 |
positive regulation of acrosome reaction(GO:2000344) |
| 0.1 |
0.2 |
GO:0002818 |
intracellular defense response(GO:0002818) |
| 0.1 |
0.4 |
GO:0050703 |
interleukin-1 alpha secretion(GO:0050703) |
| 0.1 |
0.2 |
GO:0001886 |
endothelial cell morphogenesis(GO:0001886) |
| 0.1 |
0.1 |
GO:0006663 |
platelet activating factor biosynthetic process(GO:0006663) |
| 0.1 |
0.1 |
GO:0070131 |
positive regulation of mitochondrial translation(GO:0070131) |
| 0.1 |
0.3 |
GO:0060612 |
adipose tissue development(GO:0060612) |
| 0.1 |
0.5 |
GO:0034723 |
DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
| 0.1 |
0.1 |
GO:0032229 |
negative regulation of synaptic transmission, GABAergic(GO:0032229) |
| 0.1 |
0.2 |
GO:0035694 |
mitochondrial protein catabolic process(GO:0035694) |
| 0.1 |
0.5 |
GO:0072126 |
positive regulation of glomerular mesangial cell proliferation(GO:0072126) |
| 0.1 |
0.2 |
GO:0051490 |
negative regulation of filopodium assembly(GO:0051490) |
| 0.1 |
0.3 |
GO:2000172 |
regulation of branching morphogenesis of a nerve(GO:2000172) |
| 0.1 |
0.1 |
GO:0035544 |
negative regulation of SNARE complex assembly(GO:0035544) |
| 0.1 |
0.1 |
GO:0030969 |
mRNA splicing via endonucleolytic cleavage and ligation involved in unfolded protein response(GO:0030969) mRNA splicing, via endonucleolytic cleavage and ligation(GO:0070054) mRNA endonucleolytic cleavage involved in unfolded protein response(GO:0070055) |
| 0.1 |
0.2 |
GO:0072661 |
protein targeting to plasma membrane(GO:0072661) |
| 0.1 |
0.2 |
GO:0000460 |
maturation of 5.8S rRNA(GO:0000460) |
| 0.1 |
0.2 |
GO:0006526 |
arginine biosynthetic process(GO:0006526) |
| 0.1 |
0.2 |
GO:0071372 |
cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
| 0.1 |
0.4 |
GO:0070544 |
histone H3-K36 demethylation(GO:0070544) |
| 0.0 |
0.1 |
GO:0090521 |
glomerular visceral epithelial cell migration(GO:0090521) |
| 0.0 |
0.4 |
GO:0060526 |
prostate glandular acinus morphogenesis(GO:0060526) prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis(GO:0060527) |
| 0.0 |
0.3 |
GO:1902914 |
regulation of protein polyubiquitination(GO:1902914) |
| 0.0 |
0.2 |
GO:0051938 |
L-glutamate import(GO:0051938) |
| 0.0 |
0.1 |
GO:2000824 |
negative regulation of androgen receptor activity(GO:2000824) |
| 0.0 |
0.1 |
GO:0046416 |
D-amino acid metabolic process(GO:0046416) |
| 0.0 |
0.2 |
GO:0016081 |
synaptic vesicle docking(GO:0016081) |
| 0.0 |
0.1 |
GO:1903362 |
regulation of cellular protein catabolic process(GO:1903362) |
| 0.0 |
0.2 |
GO:2000382 |
positive regulation of mesoderm development(GO:2000382) |
| 0.0 |
0.4 |
GO:0006384 |
transcription initiation from RNA polymerase III promoter(GO:0006384) |
| 0.0 |
0.0 |
GO:0051932 |
synaptic transmission, GABAergic(GO:0051932) |
| 0.0 |
0.2 |
GO:0006710 |
androgen catabolic process(GO:0006710) |
| 0.0 |
0.2 |
GO:0001658 |
branching involved in ureteric bud morphogenesis(GO:0001658) |
| 0.0 |
0.1 |
GO:0051095 |
regulation of helicase activity(GO:0051095) |
| 0.0 |
0.0 |
GO:1900227 |
positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
| 0.0 |
0.2 |
GO:1904430 |
negative regulation of t-circle formation(GO:1904430) |
| 0.0 |
0.1 |
GO:1903697 |
negative regulation of microvillus assembly(GO:1903697) |
| 0.0 |
0.3 |
GO:0035137 |
hindlimb morphogenesis(GO:0035137) |
| 0.0 |
0.1 |
GO:1900273 |
positive regulation of long-term synaptic potentiation(GO:1900273) |
| 0.0 |
0.4 |
GO:0008045 |
motor neuron axon guidance(GO:0008045) |
| 0.0 |
0.1 |
GO:1901880 |
regulation of protein complex disassembly(GO:0043244) negative regulation of protein depolymerization(GO:1901880) |
| 0.0 |
0.1 |
GO:0060762 |
regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
| 0.0 |
0.2 |
GO:0033005 |
positive regulation of mast cell activation(GO:0033005) positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
| 0.0 |
1.3 |
GO:0009235 |
cobalamin metabolic process(GO:0009235) |
| 0.0 |
0.0 |
GO:0010936 |
negative regulation of macrophage cytokine production(GO:0010936) |
| 0.0 |
0.5 |
GO:0016242 |
negative regulation of macroautophagy(GO:0016242) |
| 0.0 |
0.6 |
GO:0071364 |
cellular response to epidermal growth factor stimulus(GO:0071364) |
| 0.0 |
0.0 |
GO:1900245 |
positive regulation of MDA-5 signaling pathway(GO:1900245) |
| 0.0 |
1.3 |
GO:0036092 |
phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
| 0.0 |
2.6 |
GO:0051865 |
protein autoubiquitination(GO:0051865) |
| 0.0 |
0.1 |
GO:1904808 |
regulation of protein oxidation(GO:1904806) positive regulation of protein oxidation(GO:1904808) |
| 0.0 |
0.2 |
GO:0051451 |
myoblast migration(GO:0051451) |
| 0.0 |
0.5 |
GO:0030091 |
protein repair(GO:0030091) |
| 0.0 |
0.4 |
GO:0046604 |
positive regulation of mitotic centrosome separation(GO:0046604) |
| 0.0 |
0.6 |
GO:0019433 |
triglyceride catabolic process(GO:0019433) |
| 0.0 |
0.3 |
GO:0032468 |
Golgi calcium ion homeostasis(GO:0032468) |
| 0.0 |
0.1 |
GO:0071394 |
cellular response to testosterone stimulus(GO:0071394) |
| 0.0 |
1.3 |
GO:0006734 |
NADH metabolic process(GO:0006734) |
| 0.0 |
0.1 |
GO:0035624 |
receptor transactivation(GO:0035624) |
| 0.0 |
0.1 |
GO:0043376 |
regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
| 0.0 |
0.1 |
GO:0043987 |
histone H3-S10 phosphorylation(GO:0043987) |
| 0.0 |
0.8 |
GO:0050829 |
defense response to Gram-negative bacterium(GO:0050829) |
| 0.0 |
1.8 |
GO:0007032 |
endosome organization(GO:0007032) |
| 0.0 |
0.1 |
GO:0050893 |
sensory processing(GO:0050893) |
| 0.0 |
0.9 |
GO:0070527 |
platelet aggregation(GO:0070527) |
| 0.0 |
0.0 |
GO:0009794 |
regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
| 0.0 |
0.8 |
GO:0060325 |
face morphogenesis(GO:0060325) |
| 0.0 |
0.2 |
GO:0072378 |
blood coagulation, fibrin clot formation(GO:0072378) |
| 0.0 |
0.2 |
GO:0006013 |
mannose metabolic process(GO:0006013) |
| 0.0 |
0.1 |
GO:0086045 |
membrane depolarization during AV node cell action potential(GO:0086045) |
| 0.0 |
0.3 |
GO:0007077 |
mitotic nuclear envelope disassembly(GO:0007077) |
| 0.0 |
0.2 |
GO:2001256 |
regulation of store-operated calcium entry(GO:2001256) |
| 0.0 |
0.3 |
GO:2000568 |
memory T cell activation(GO:0035709) regulation of memory T cell activation(GO:2000567) positive regulation of memory T cell activation(GO:2000568) |
| 0.0 |
0.5 |
GO:0048569 |
post-embryonic organ development(GO:0048569) |
| 0.0 |
2.3 |
GO:0016126 |
sterol biosynthetic process(GO:0016126) |
| 0.0 |
0.3 |
GO:0036151 |
phosphatidylcholine acyl-chain remodeling(GO:0036151) |
| 0.0 |
1.0 |
GO:0008333 |
endosome to lysosome transport(GO:0008333) |
| 0.0 |
0.0 |
GO:0048672 |
positive regulation of collateral sprouting(GO:0048672) |
| 0.0 |
0.1 |
GO:0060707 |
trophoblast giant cell differentiation(GO:0060707) |
| 0.0 |
0.4 |
GO:0006658 |
phosphatidylserine metabolic process(GO:0006658) |
| 0.0 |
0.1 |
GO:0018195 |
peptidyl-arginine modification(GO:0018195) |
| 0.0 |
0.1 |
GO:0021503 |
neural fold bending(GO:0021503) |
| 0.0 |
0.7 |
GO:1903845 |
negative regulation of cellular response to transforming growth factor beta stimulus(GO:1903845) |
| 0.0 |
0.1 |
GO:0034201 |
response to oleic acid(GO:0034201) |
| 0.0 |
0.2 |
GO:0061635 |
regulation of protein complex stability(GO:0061635) |
| 0.0 |
0.5 |
GO:0006703 |
estrogen biosynthetic process(GO:0006703) |
| 0.0 |
0.6 |
GO:0042753 |
positive regulation of circadian rhythm(GO:0042753) |
| 0.0 |
1.0 |
GO:0045066 |
regulatory T cell differentiation(GO:0045066) |
| 0.0 |
0.2 |
GO:0030259 |
lipid glycosylation(GO:0030259) |
| 0.0 |
0.1 |
GO:0051216 |
cartilage development(GO:0051216) |
| 0.0 |
0.2 |
GO:0001555 |
oocyte growth(GO:0001555) |
| 0.0 |
0.1 |
GO:0034113 |
heterotypic cell-cell adhesion(GO:0034113) |
| 0.0 |
0.1 |
GO:0090303 |
positive regulation of wound healing(GO:0090303) |
| 0.0 |
0.5 |
GO:0090004 |
positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
| 0.0 |
0.0 |
GO:2000676 |
positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
| 0.0 |
0.1 |
GO:0090598 |
male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
| 0.0 |
2.5 |
GO:0007218 |
neuropeptide signaling pathway(GO:0007218) |
| 0.0 |
0.2 |
GO:0051001 |
negative regulation of nitric-oxide synthase activity(GO:0051001) |
| 0.0 |
0.2 |
GO:0021854 |
hypothalamus development(GO:0021854) |
| 0.0 |
0.1 |
GO:0050942 |
positive regulation of pigment cell differentiation(GO:0050942) |
| 0.0 |
0.4 |
GO:0097106 |
postsynaptic density organization(GO:0097106) |
| 0.0 |
0.0 |
GO:0050885 |
neuromuscular process controlling balance(GO:0050885) |
| 0.0 |
0.1 |
GO:0010042 |
response to manganese ion(GO:0010042) |
| 0.0 |
0.4 |
GO:0048008 |
platelet-derived growth factor receptor signaling pathway(GO:0048008) |
| 0.0 |
1.1 |
GO:0043154 |
negative regulation of cysteine-type endopeptidase activity involved in apoptotic process(GO:0043154) |
| 0.0 |
0.2 |
GO:0000132 |
establishment of mitotic spindle orientation(GO:0000132) |
| 0.0 |
0.1 |
GO:0060148 |
positive regulation of posttranscriptional gene silencing(GO:0060148) positive regulation of gene silencing by miRNA(GO:2000637) |
| 0.0 |
0.3 |
GO:0035641 |
locomotory exploration behavior(GO:0035641) |
| 0.0 |
0.1 |
GO:0003100 |
regulation of systemic arterial blood pressure by endothelin(GO:0003100) |
| 0.0 |
0.3 |
GO:0006689 |
ganglioside catabolic process(GO:0006689) |
| 0.0 |
0.4 |
GO:0048305 |
immunoglobulin secretion(GO:0048305) |
| 0.0 |
0.3 |
GO:0007635 |
chemosensory behavior(GO:0007635) |
| 0.0 |
0.1 |
GO:0006434 |
seryl-tRNA aminoacylation(GO:0006434) |
| 0.0 |
0.0 |
GO:0034371 |
chylomicron remodeling(GO:0034371) |
| 0.0 |
1.4 |
GO:1901998 |
toxin transport(GO:1901998) |
| 0.0 |
0.0 |
GO:0010508 |
positive regulation of autophagy(GO:0010508) |
| 0.0 |
0.1 |
GO:0001777 |
T cell homeostatic proliferation(GO:0001777) |
| 0.0 |
0.2 |
GO:0043248 |
proteasome assembly(GO:0043248) |
| 0.0 |
0.0 |
GO:0097360 |
chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
| 0.0 |
0.1 |
GO:0043011 |
myeloid dendritic cell differentiation(GO:0043011) |
| 0.0 |
0.3 |
GO:0018214 |
peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
| 0.0 |
0.4 |
GO:0010470 |
regulation of gastrulation(GO:0010470) |
| 0.0 |
0.2 |
GO:0039529 |
RIG-I signaling pathway(GO:0039529) |
| 0.0 |
0.1 |
GO:0060628 |
regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
| 0.0 |
0.3 |
GO:0006772 |
thiamine metabolic process(GO:0006772) |
| 0.0 |
0.2 |
GO:0000066 |
mitochondrial ornithine transport(GO:0000066) |
| 0.0 |
0.0 |
GO:0021516 |
dorsal spinal cord development(GO:0021516) |
| 0.0 |
0.9 |
GO:0090002 |
establishment of protein localization to plasma membrane(GO:0090002) |
| 0.0 |
0.3 |
GO:0007229 |
integrin-mediated signaling pathway(GO:0007229) |
| 0.0 |
0.1 |
GO:1900449 |
regulation of glutamate receptor signaling pathway(GO:1900449) |
| 0.0 |
0.1 |
GO:1901096 |
regulation of autophagosome maturation(GO:1901096) |
| 0.0 |
0.1 |
GO:0002528 |
regulation of vascular permeability involved in acute inflammatory response(GO:0002528) |
| 0.0 |
0.1 |
GO:0035020 |
regulation of Rac protein signal transduction(GO:0035020) |
| 0.0 |
0.1 |
GO:0060397 |
JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
| 0.0 |
1.1 |
GO:0008088 |
axo-dendritic transport(GO:0008088) |
| 0.0 |
0.2 |
GO:0001675 |
acrosome assembly(GO:0001675) |
| 0.0 |
0.1 |
GO:0072665 |
protein localization to vacuole(GO:0072665) |
| 0.0 |
0.1 |
GO:0051354 |
negative regulation of oxidoreductase activity(GO:0051354) |
| 0.0 |
0.2 |
GO:0097264 |
self proteolysis(GO:0097264) |
| 0.0 |
0.2 |
GO:0000056 |
ribosomal small subunit export from nucleus(GO:0000056) |
| 0.0 |
0.7 |
GO:0032456 |
endocytic recycling(GO:0032456) |
| 0.0 |
0.1 |
GO:0043124 |
negative regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043124) |
| 0.0 |
0.1 |
GO:0048133 |
germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
| 0.0 |
0.1 |
GO:0048262 |
determination of dorsal/ventral asymmetry(GO:0048262) |
| 0.0 |
0.2 |
GO:0002191 |
cap-dependent translational initiation(GO:0002191) |
| 0.0 |
0.2 |
GO:0034421 |
post-translational protein acetylation(GO:0034421) |
| 0.0 |
0.0 |
GO:0014012 |
peripheral nervous system axon regeneration(GO:0014012) |
| 0.0 |
0.1 |
GO:0002291 |
T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
| 0.0 |
0.1 |
GO:0072553 |
terminal button organization(GO:0072553) |
| 0.0 |
0.1 |
GO:0015942 |
formate metabolic process(GO:0015942) histidine catabolic process to glutamate and formamide(GO:0019556) histidine catabolic process to glutamate and formate(GO:0019557) formamide metabolic process(GO:0043606) |
| 0.0 |
0.0 |
GO:0032094 |
response to food(GO:0032094) |
| 0.0 |
0.2 |
GO:0050910 |
detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
| 0.0 |
0.2 |
GO:0001825 |
blastocyst formation(GO:0001825) |
| 0.0 |
0.8 |
GO:0015721 |
bile acid and bile salt transport(GO:0015721) |
| 0.0 |
0.2 |
GO:0030050 |
vesicle transport along actin filament(GO:0030050) |
| 0.0 |
0.1 |
GO:1902018 |
negative regulation of cilium assembly(GO:1902018) |
| 0.0 |
0.5 |
GO:0000338 |
protein deneddylation(GO:0000338) |
| 0.0 |
0.3 |
GO:0050710 |
negative regulation of cytokine secretion(GO:0050710) |
| 0.0 |
0.2 |
GO:0030201 |
heparan sulfate proteoglycan metabolic process(GO:0030201) |
| 0.0 |
0.3 |
GO:0015860 |
purine nucleoside transmembrane transport(GO:0015860) |
| 0.0 |
0.1 |
GO:0034182 |
regulation of maintenance of sister chromatid cohesion(GO:0034091) positive regulation of maintenance of sister chromatid cohesion(GO:0034093) regulation of maintenance of mitotic sister chromatid cohesion(GO:0034182) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
| 0.0 |
0.3 |
GO:0042573 |
retinoic acid metabolic process(GO:0042573) |
| 0.0 |
0.2 |
GO:0055129 |
L-proline biosynthetic process(GO:0055129) |
| 0.0 |
0.1 |
GO:0009253 |
peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
| 0.0 |
0.1 |
GO:0015886 |
heme transport(GO:0015886) iron coordination entity transport(GO:1901678) |
| 0.0 |
0.1 |
GO:0060099 |
regulation of phagocytosis, engulfment(GO:0060099) |
| 0.0 |
0.0 |
GO:1902083 |
negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
| 0.0 |
0.0 |
GO:0032241 |
positive regulation of nucleobase-containing compound transport(GO:0032241) positive regulation of RNA export from nucleus(GO:0046833) |
| 0.0 |
0.2 |
GO:0051715 |
cytolysis in other organism(GO:0051715) |
| 0.0 |
0.1 |
GO:0060282 |
positive regulation of oocyte development(GO:0060282) |
| 0.0 |
0.4 |
GO:0032875 |
regulation of DNA endoreduplication(GO:0032875) DNA endoreduplication(GO:0042023) |
| 0.0 |
0.1 |
GO:0006681 |
galactosylceramide metabolic process(GO:0006681) galactolipid metabolic process(GO:0019374) |
| 0.0 |
0.2 |
GO:0019359 |
nicotinamide nucleotide biosynthetic process(GO:0019359) pyridine nucleotide biosynthetic process(GO:0019363) |
| 0.0 |
0.4 |
GO:0030835 |
negative regulation of actin filament depolymerization(GO:0030835) |
| 0.0 |
0.5 |
GO:0034097 |
response to cytokine(GO:0034097) |
| 0.0 |
0.0 |
GO:0032414 |
positive regulation of ion transmembrane transporter activity(GO:0032414) |
| 0.0 |
0.2 |
GO:0090435 |
protein localization to nuclear envelope(GO:0090435) |
| 0.0 |
0.4 |
GO:0042058 |
regulation of epidermal growth factor receptor signaling pathway(GO:0042058) |
| 0.0 |
0.2 |
GO:0015742 |
alpha-ketoglutarate transport(GO:0015742) |
| 0.0 |
0.2 |
GO:0045663 |
positive regulation of myoblast differentiation(GO:0045663) |
| 0.0 |
0.2 |
GO:0050819 |
negative regulation of coagulation(GO:0050819) |
| 0.0 |
0.2 |
GO:0016264 |
gap junction assembly(GO:0016264) |
| 0.0 |
0.1 |
GO:0010212 |
response to ionizing radiation(GO:0010212) |
| 0.0 |
0.1 |
GO:0070475 |
rRNA base methylation(GO:0070475) |
| 0.0 |
0.1 |
GO:0019417 |
sulfur oxidation(GO:0019417) |
| 0.0 |
0.0 |
GO:0003160 |
endocardium morphogenesis(GO:0003160) |
| 0.0 |
0.2 |
GO:0001967 |
suckling behavior(GO:0001967) |
| 0.0 |
0.1 |
GO:1900017 |
positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
| 0.0 |
0.1 |
GO:0033341 |
regulation of collagen binding(GO:0033341) |
| 0.0 |
0.1 |
GO:0003322 |
pancreatic A cell development(GO:0003322) |
| 0.0 |
1.2 |
GO:0006362 |
transcription elongation from RNA polymerase I promoter(GO:0006362) |
| 0.0 |
0.2 |
GO:0097061 |
dendritic spine organization(GO:0097061) |
| 0.0 |
0.0 |
GO:0006084 |
acetyl-CoA metabolic process(GO:0006084) |
| 0.0 |
0.1 |
GO:0030947 |
regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030947) |
| 0.0 |
0.1 |
GO:0090312 |
positive regulation of protein deacetylation(GO:0090312) |
| 0.0 |
1.3 |
GO:0010501 |
RNA secondary structure unwinding(GO:0010501) |
| 0.0 |
0.2 |
GO:0034162 |
toll-like receptor 9 signaling pathway(GO:0034162) |
| 0.0 |
0.2 |
GO:0035635 |
entry of bacterium into host cell(GO:0035635) |
| 0.0 |
0.2 |
GO:0060080 |
inhibitory postsynaptic potential(GO:0060080) |
| 0.0 |
0.1 |
GO:0010533 |
regulation of activation of Janus kinase activity(GO:0010533) |
| 0.0 |
0.2 |
GO:0000469 |
cleavage involved in rRNA processing(GO:0000469) |
| 0.0 |
0.0 |
GO:0010952 |
positive regulation of peptidase activity(GO:0010952) |
| 0.0 |
0.1 |
GO:0048753 |
pigment granule organization(GO:0048753) |
| 0.0 |
0.0 |
GO:0035418 |
protein localization to synapse(GO:0035418) |
| 0.0 |
1.3 |
GO:0007179 |
transforming growth factor beta receptor signaling pathway(GO:0007179) |
| 0.0 |
0.1 |
GO:0071731 |
response to nitric oxide(GO:0071731) cellular response to nitric oxide(GO:0071732) |
| 0.0 |
0.3 |
GO:0072678 |
T cell migration(GO:0072678) |
| 0.0 |
2.3 |
GO:0070268 |
cornification(GO:0070268) |
| 0.0 |
0.0 |
GO:0071504 |
cellular response to heparin(GO:0071504) |
| 0.0 |
0.3 |
GO:0035331 |
negative regulation of hippo signaling(GO:0035331) |
| 0.0 |
0.1 |
GO:0033211 |
adiponectin-activated signaling pathway(GO:0033211) |
| 0.0 |
0.1 |
GO:1902775 |
mitochondrial large ribosomal subunit assembly(GO:1902775) |
| 0.0 |
0.3 |
GO:0035855 |
megakaryocyte development(GO:0035855) |
| 0.0 |
0.5 |
GO:0001890 |
placenta development(GO:0001890) |
| 0.0 |
0.2 |
GO:0031061 |
negative regulation of histone methylation(GO:0031061) |
| 0.0 |
0.7 |
GO:0097341 |
inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) |
| 0.0 |
0.1 |
GO:0030186 |
melatonin metabolic process(GO:0030186) melatonin biosynthetic process(GO:0030187) |
| 0.0 |
0.0 |
GO:0031998 |
regulation of fatty acid beta-oxidation(GO:0031998) |
| 0.0 |
0.2 |
GO:0033198 |
response to ATP(GO:0033198) |
| 0.0 |
0.1 |
GO:1903265 |
positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
| 0.0 |
0.2 |
GO:0070934 |
CRD-mediated mRNA stabilization(GO:0070934) |
| 0.0 |
0.0 |
GO:0006286 |
base-excision repair, base-free sugar-phosphate removal(GO:0006286) |
| 0.0 |
0.4 |
GO:0043534 |
blood vessel endothelial cell migration(GO:0043534) |
| 0.0 |
0.2 |
GO:1990564 |
protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
| 0.0 |
0.0 |
GO:0099500 |
synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
| 0.0 |
0.1 |
GO:0010499 |
proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
| 0.0 |
0.2 |
GO:1901072 |
glucosamine-containing compound catabolic process(GO:1901072) |
| 0.0 |
0.2 |
GO:0030513 |
positive regulation of BMP signaling pathway(GO:0030513) |
| 0.0 |
0.1 |
GO:0030539 |
male genitalia development(GO:0030539) |
| 0.0 |
0.1 |
GO:0002158 |
osteoclast proliferation(GO:0002158) |
| 0.0 |
0.3 |
GO:0034204 |
lipid translocation(GO:0034204) phospholipid translocation(GO:0045332) |
| 0.0 |
0.1 |
GO:0051930 |
regulation of sensory perception of pain(GO:0051930) regulation of sensory perception(GO:0051931) |
| 0.0 |
0.5 |
GO:0086010 |
membrane depolarization during action potential(GO:0086010) |
| 0.0 |
0.2 |
GO:2000401 |
regulation of lymphocyte migration(GO:2000401) |
| 0.0 |
0.1 |
GO:0009822 |
alkaloid catabolic process(GO:0009822) |
| 0.0 |
0.1 |
GO:0061029 |
eyelid development in camera-type eye(GO:0061029) |
| 0.0 |
0.0 |
GO:1990785 |
response to water-immersion restraint stress(GO:1990785) |
| 0.0 |
0.3 |
GO:0032620 |
interleukin-17 production(GO:0032620) |
| 0.0 |
0.0 |
GO:0007190 |
activation of adenylate cyclase activity(GO:0007190) |
| 0.0 |
0.0 |
GO:1901569 |
leukotriene catabolic process(GO:0036100) leukotriene B4 catabolic process(GO:0036101) leukotriene B4 metabolic process(GO:0036102) long-chain fatty acid catabolic process(GO:0042758) icosanoid catabolic process(GO:1901523) fatty acid derivative catabolic process(GO:1901569) |
| 0.0 |
0.2 |
GO:0046852 |
positive regulation of bone resorption(GO:0045780) positive regulation of bone remodeling(GO:0046852) |
| 0.0 |
0.3 |
GO:0005513 |
detection of calcium ion(GO:0005513) |
| 0.0 |
0.1 |
GO:0008612 |
peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
| 0.0 |
0.4 |
GO:0034629 |
cellular protein complex localization(GO:0034629) |
| 0.0 |
0.2 |
GO:0001938 |
positive regulation of endothelial cell proliferation(GO:0001938) |
| 0.0 |
0.1 |
GO:0019934 |
cGMP-mediated signaling(GO:0019934) |
| 0.0 |
0.5 |
GO:0006654 |
phosphatidic acid biosynthetic process(GO:0006654) |
| 0.0 |
0.2 |
GO:0006144 |
purine nucleobase metabolic process(GO:0006144) |
| 0.0 |
0.1 |
GO:0010880 |
regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum(GO:0010880) |
| 0.0 |
0.1 |
GO:0046697 |
decidualization(GO:0046697) |
| 0.0 |
0.0 |
GO:0051883 |
disruption of cells of other organism involved in symbiotic interaction(GO:0051818) killing of cells in other organism involved in symbiotic interaction(GO:0051883) |
| 0.0 |
1.3 |
GO:0000079 |
regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) |
| 0.0 |
0.1 |
GO:0090190 |
positive regulation of branching involved in ureteric bud morphogenesis(GO:0090190) |
| 0.0 |
0.7 |
GO:0008344 |
adult locomotory behavior(GO:0008344) |
| 0.0 |
0.1 |
GO:1902031 |
regulation of NADP metabolic process(GO:1902031) |
| 0.0 |
0.4 |
GO:0043252 |
sodium-independent organic anion transport(GO:0043252) |
| 0.0 |
0.1 |
GO:0032594 |
protein transport within lipid bilayer(GO:0032594) |
| 0.0 |
0.1 |
GO:0060135 |
maternal process involved in female pregnancy(GO:0060135) |
| 0.0 |
0.5 |
GO:0000188 |
inactivation of MAPK activity(GO:0000188) |
| 0.0 |
0.2 |
GO:0050901 |
leukocyte tethering or rolling(GO:0050901) |
| 0.0 |
0.0 |
GO:0006271 |
DNA strand elongation involved in DNA replication(GO:0006271) |
| 0.0 |
0.3 |
GO:0000470 |
maturation of LSU-rRNA(GO:0000470) |
| 0.0 |
0.1 |
GO:0034227 |
tRNA thio-modification(GO:0034227) |
| 0.0 |
0.1 |
GO:0048520 |
positive regulation of behavior(GO:0048520) |
| 0.0 |
0.1 |
GO:0030202 |
heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
| 0.0 |
0.2 |
GO:0032148 |
activation of protein kinase B activity(GO:0032148) |
| 0.0 |
0.1 |
GO:0090208 |
positive regulation of triglyceride metabolic process(GO:0090208) |
| 0.0 |
0.1 |
GO:0051697 |
protein delipidation(GO:0051697) |
| 0.0 |
0.1 |
GO:0030223 |
neutrophil differentiation(GO:0030223) |
| 0.0 |
0.0 |
GO:0032482 |
Rab protein signal transduction(GO:0032482) |
| 0.0 |
0.5 |
GO:0019835 |
cytolysis(GO:0019835) |
| 0.0 |
0.1 |
GO:0006268 |
DNA unwinding involved in DNA replication(GO:0006268) |
| 0.0 |
0.1 |
GO:0048483 |
autonomic nervous system development(GO:0048483) |
| 0.0 |
0.1 |
GO:0006436 |
tryptophanyl-tRNA aminoacylation(GO:0006436) |
| 0.0 |
0.0 |
GO:0045026 |
plasma membrane fusion(GO:0045026) |
| 0.0 |
0.1 |
GO:0071560 |
cellular response to transforming growth factor beta stimulus(GO:0071560) |
| 0.0 |
0.1 |
GO:0046580 |
negative regulation of Ras protein signal transduction(GO:0046580) |
| 0.0 |
0.0 |
GO:0001787 |
natural killer cell proliferation(GO:0001787) |
| 0.0 |
0.1 |
GO:0000060 |
protein import into nucleus, translocation(GO:0000060) |
| 0.0 |
0.1 |
GO:0045835 |
negative regulation of meiotic nuclear division(GO:0045835) |
| 0.0 |
0.1 |
GO:0016480 |
negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
| 0.0 |
0.2 |
GO:0032781 |
positive regulation of ATPase activity(GO:0032781) |
| 0.0 |
0.0 |
GO:0099566 |
regulation of postsynaptic cytosolic calcium ion concentration(GO:0099566) |
| 0.0 |
0.1 |
GO:0090168 |
Golgi reassembly(GO:0090168) |
| 0.0 |
0.1 |
GO:0032364 |
oxygen homeostasis(GO:0032364) |
| 0.0 |
0.1 |
GO:0006449 |
regulation of translational termination(GO:0006449) |
| 0.0 |
0.1 |
GO:0006103 |
2-oxoglutarate metabolic process(GO:0006103) |
| 0.0 |
0.2 |
GO:0045824 |
negative regulation of innate immune response(GO:0045824) |
| 0.0 |
0.0 |
GO:0006924 |
activation-induced cell death of T cells(GO:0006924) |
| 0.0 |
0.0 |
GO:0099627 |
neurotransmitter receptor cycle(GO:0099627) postsynaptic neurotransmitter receptor cycle(GO:0099630) |
| 0.0 |
0.1 |
GO:0007000 |
nucleolus organization(GO:0007000) |
| 0.0 |
0.1 |
GO:0070932 |
histone H3 deacetylation(GO:0070932) |
| 0.0 |
0.1 |
GO:0051898 |
negative regulation of protein kinase B signaling(GO:0051898) |
| 0.0 |
0.0 |
GO:2001021 |
negative regulation of response to DNA damage stimulus(GO:2001021) |
| 0.0 |
0.1 |
GO:0010518 |
positive regulation of phospholipase activity(GO:0010518) |
| 0.0 |
0.1 |
GO:0034122 |
negative regulation of toll-like receptor signaling pathway(GO:0034122) |
| 0.0 |
0.0 |
GO:1904948 |
midbrain dopaminergic neuron differentiation(GO:1904948) |
| 0.0 |
0.0 |
GO:0006428 |
isoleucyl-tRNA aminoacylation(GO:0006428) |
| 0.0 |
0.1 |
GO:0000244 |
spliceosomal tri-snRNP complex assembly(GO:0000244) |
| 0.0 |
0.0 |
GO:0001953 |
negative regulation of cell-matrix adhesion(GO:0001953) |
| 0.0 |
0.1 |
GO:0040033 |
miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
| 0.0 |
0.0 |
GO:0010044 |
response to aluminum ion(GO:0010044) |
| 0.0 |
0.0 |
GO:0060071 |
Wnt signaling pathway, planar cell polarity pathway(GO:0060071) regulation of establishment of planar polarity(GO:0090175) |
| 0.0 |
0.0 |
GO:0000186 |
activation of MAPKK activity(GO:0000186) |
| 0.0 |
0.0 |
GO:0016246 |
RNA interference(GO:0016246) |
| 0.0 |
0.1 |
GO:0034244 |
negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
| 0.0 |
0.0 |
GO:0023016 |
signal transduction by trans-phosphorylation(GO:0023016) |
| 0.0 |
0.2 |
GO:0070262 |
peptidyl-serine dephosphorylation(GO:0070262) |
| 0.0 |
0.1 |
GO:0016486 |
peptide hormone processing(GO:0016486) |
| 0.0 |
0.1 |
GO:0046475 |
glycerophospholipid catabolic process(GO:0046475) |
| 0.0 |
0.2 |
GO:0006607 |
NLS-bearing protein import into nucleus(GO:0006607) |
| 0.0 |
0.1 |
GO:0043392 |
negative regulation of DNA binding(GO:0043392) |
| 0.0 |
0.2 |
GO:1903830 |
magnesium ion transmembrane transport(GO:1903830) |
| 0.0 |
0.1 |
GO:0016998 |
cell wall macromolecule catabolic process(GO:0016998) |
| 0.0 |
0.2 |
GO:0001541 |
ovarian follicle development(GO:0001541) |
